Calibration Methods Used in Cancer Simulation Models and Suggested Reporting Guidelines
Increasingly, computer simulation models are used for economic and policy evaluation in cancer prevention and control. A model’s predictions of key outcomes, such as screening effectiveness, depend on the values of unobservable natural history parameters. Calibration is the process of determining th...
Saved in:
Published in | PharmacoEconomics Vol. 27; no. 7; pp. 533 - 545 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Cham
Springer International Publishing
01.01.2009
Adis International Springer Healthcare | Adis Wolters Kluwer Health, Inc Springer Nature B.V |
Series | PharmacoEconomics |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Increasingly, computer simulation models are used for economic and policy evaluation in cancer prevention and control. A model’s predictions of key outcomes, such as screening effectiveness, depend on the values of unobservable natural history parameters. Calibration is the process of determining the values of unobservable parameters by constraining model output to replicate observed data. Because there are many approaches for model calibration and little consensus on best practices, we surveyed the literature to catalogue the use and reporting of these methods in cancer simulation models.
We conducted a MEDLINE search (1980 through 2006) for articles on cancer-screening models and supplemented search results with articles from our personal reference databases. For each article, two authors independently abstracted pre-determined items using a standard form. Data items included cancer site, model type, methods used for determination of unobservable parameter values and description of any calibration protocol. All authors reached consensus on items of disagreement. Reviews and non-cancer models were excluded. Articles describing analytical models, which estimate parameters with statistical approaches (e.g. maximum likelihood) were catalogued separately.Models that included unobservable parameters were analysed and classified by whether calibration methods were reported and if so, the methods used.
The review process yielded 154 articles that met our inclusion criteria and, of these, we concluded that 131 may have used calibration methods to determine model parameters. Although the term ‘calibration’ was not always used, descriptions of calibration or ‘model fitting’ were found in 50% (n = 66) of the articles, with an additional 16% (n = 21) providing a reference to methods. Calibration target data were identified in nearly all of these articles. Other methodological details, such as the goodness-of-fit metric, were discussed in 54% (n = 47 of 87) of the articles reporting calibration methods, while few details were provided on the algorithms used to search the parameter space.
Our review shows that the use of cancer simulation modelling is increasing, although thorough descriptions of calibration procedures are rare in the published literature for these models. Calibration is a key component of model development and is central to the validity and credibility of subsequent analyses and inferences drawn from model predictions. To aid peer-review and facilitate discussion of modelling methods, we propose a standardized Calibration Reporting Checklist for model documentation. |
---|---|
AbstractList | Increasingly, computer simulation models are used for economic and policy evaluation in cancer prevention and control. A model's predictions of key outcomes, such as screening effectiveness, depend on the values of unobservable natural history parameters. Calibration is the process of determining the values of unobservable parameters by constraining model output to replicate observed data. Because there are many approaches for model calibration and little consensus on best practices, we surveyed the literature to catalogue the use and reporting of these methods in cancer simulation models. We conducted a MEDLINE search (1980 through 2006) for articles on cancer-screening models and supplemented search results with articles from our personal reference databases. For each article, two authors independently abstracted pre-determined items using a standard form. Data items included cancer site, model type, methods used for determination of unobservable parameter values and description of any calibration protocol. All authors reached consensus on items of disagreement. Reviews and non-cancer models were excluded. Articles describing analytical models, which estimate parameters with statistical approaches (e.g. maximum likelihood) were catalogued separately. Models that included unobservable parameters were analysed and classified by whether calibration methods were reported and if so, the methods used. The review process yielded 154 articles that met our inclusion criteria and, of these, we concluded that 131 may have used calibration methods to determine model parameters. Although the term 'calibration' was not always used, descriptions of calibration or 'model fitting' were found in 50% (n = 66) of the articles, with an additional 16% (n = 21) providing a reference to methods. Calibration target data were identified in nearly all of these articles. Other methodological details, such as the goodness-of-fit metric, were discussed in 54% (n = 47 of 87) of the articles reporting calibration methods, while few details were provided on the algorithms used to search the parameter space. Our review shows that the use of cancer simulation modelling is increasing, although thorough descriptions of calibration procedures are rare in the published literature for these models. Calibration is a key component of model development and is central to the validity and credibility of subsequent analyses and inferences drawn from model predictions. To aid peer-review and facilitate discussion of modelling methods, we propose a standardized Calibration Reporting Checklist for model documentation. Increasingly, computer simulation models are used for economic and policy evaluation in cancer prevention and control. A model's predictions of key outcomes, such as screening effectiveness, depend on the values of unobservable natural history parameters. Calibration is the process of determining the values of unobservable parameters by constraining model output to replicate observed data. Because there are many approaches for model calibration and little consensus on best practices, we surveyed the literature to catalogue the use and reporting of these methods in cancer simulation models. We conducted a MEDLINE search (1980 through 2006) for articles on cancer-screening models and supplemented search results with articles from our personal reference databases. For each article, two authors independently abstracted pre-determined items using a standard form. Data items included cancer site, model type, methods used for determination of unobservable parameter values and description of any calibration protocol. All authors reached consensus on items of disagreement. Reviews and non-cancer models were excluded. Articles describing analytical models, which estimate parameters with statistical approaches (e.g. maximum likelihood) were catalogued separately. Models that included unobservable parameters were analysed and classified by whether calibration methods were reported and if so, the methods used. The review process yielded 154 articles that met our inclusion criteria and, of these, we concluded that 131 may have used calibration methods to determine model parameters. Although the term 'calibration' was not always used, descriptions of calibration or 'model fitting' were found in 50% (n = 66) of the articles, with an additional 16% (n = 21) providing a reference to methods. Calibration target data were identified in nearly all of these articles. Other methodological details, such as the goodness-of-fit metric, were discussed in 54% (n = 47 of 87) of the articles reporting calibration methods, while few details were provided on the algorithms used to search the parameter space. Our review shows that the use of cancer simulation modelling is increasing, although thorough descriptions of calibration procedures are rare in the published literature for these models. Calibration is a key component of model development and is central to the validity and credibility of subsequent analyses and inferences drawn from model predictions. To aid peer-review and facilitate discussion of modelling methods, we propose a standardized Calibration Reporting Checklist for model documentation.Increasingly, computer simulation models are used for economic and policy evaluation in cancer prevention and control. A model's predictions of key outcomes, such as screening effectiveness, depend on the values of unobservable natural history parameters. Calibration is the process of determining the values of unobservable parameters by constraining model output to replicate observed data. Because there are many approaches for model calibration and little consensus on best practices, we surveyed the literature to catalogue the use and reporting of these methods in cancer simulation models. We conducted a MEDLINE search (1980 through 2006) for articles on cancer-screening models and supplemented search results with articles from our personal reference databases. For each article, two authors independently abstracted pre-determined items using a standard form. Data items included cancer site, model type, methods used for determination of unobservable parameter values and description of any calibration protocol. All authors reached consensus on items of disagreement. Reviews and non-cancer models were excluded. Articles describing analytical models, which estimate parameters with statistical approaches (e.g. maximum likelihood) were catalogued separately. Models that included unobservable parameters were analysed and classified by whether calibration methods were reported and if so, the methods used. The review process yielded 154 articles that met our inclusion criteria and, of these, we concluded that 131 may have used calibration methods to determine model parameters. Although the term 'calibration' was not always used, descriptions of calibration or 'model fitting' were found in 50% (n = 66) of the articles, with an additional 16% (n = 21) providing a reference to methods. Calibration target data were identified in nearly all of these articles. Other methodological details, such as the goodness-of-fit metric, were discussed in 54% (n = 47 of 87) of the articles reporting calibration methods, while few details were provided on the algorithms used to search the parameter space. Our review shows that the use of cancer simulation modelling is increasing, although thorough descriptions of calibration procedures are rare in the published literature for these models. Calibration is a key component of model development and is central to the validity and credibility of subsequent analyses and inferences drawn from model predictions. To aid peer-review and facilitate discussion of modelling methods, we propose a standardized Calibration Reporting Checklist for model documentation. Increasingly, computer simulation models are used for economic and policy evaluation in cancer prevention and control. A model’s predictions of key outcomes, such as screening effectiveness, depend on the values of unobservable natural history parameters. Calibration is the process of determining the values of unobservable parameters by constraining model output to replicate observed data. Because there are many approaches for model calibration and little consensus on best practices, we surveyed the literature to catalogue the use and reporting of these methods in cancer simulation models. We conducted a MEDLINE search (1980 through 2006) for articles on cancer-screening models and supplemented search results with articles from our personal reference databases. For each article, two authors independently abstracted pre-determined items using a standard form. Data items included cancer site, model type, methods used for determination of unobservable parameter values and description of any calibration protocol. All authors reached consensus on items of disagreement. Reviews and non-cancer models were excluded. Articles describing analytical models, which estimate parameters with statistical approaches (e.g. maximum likelihood) were catalogued separately.Models that included unobservable parameters were analysed and classified by whether calibration methods were reported and if so, the methods used. The review process yielded 154 articles that met our inclusion criteria and, of these, we concluded that 131 may have used calibration methods to determine model parameters. Although the term ‘calibration’ was not always used, descriptions of calibration or ‘model fitting’ were found in 50% (n = 66) of the articles, with an additional 16% (n = 21) providing a reference to methods. Calibration target data were identified in nearly all of these articles. Other methodological details, such as the goodness-of-fit metric, were discussed in 54% (n = 47 of 87) of the articles reporting calibration methods, while few details were provided on the algorithms used to search the parameter space. Our review shows that the use of cancer simulation modelling is increasing, although thorough descriptions of calibration procedures are rare in the published literature for these models. Calibration is a key component of model development and is central to the validity and credibility of subsequent analyses and inferences drawn from model predictions. To aid peer-review and facilitate discussion of modelling methods, we propose a standardized Calibration Reporting Checklist for model documentation. Increasingly, computer simulation models are used for economic and policy evaluation in cancer prevention and control. A model's predictions of key outcomes, such as screening effectiveness, depend on the values of unobservable natural history parameters. Calibration is the process of determining the values of unobservable parameters by constraining model output to replicate observed data. Because there are many approaches for model calibration and little consensus on best practices, we surveyed the literature to catalogue the use and reporting of these methods in cancer simulation models. We conducted a MEDLINE search (1980 through 2006) for articles on cancer-screening models and supplemented search results with articles from our personal reference databases. For each article, two authors independently abstracted pre-determined items using a standard form. Data items included cancer site, model type, methods used for determination of unobservable parameter values and description of any calibration protocol. All authors reached consensus on items of disagreement. Reviews and non-cancer models were excluded. Articles describing analytical models, which estimate parameters with statistical approaches (e.g. maximum likelihood) were catalogued separately. Models that included unobservable parameters were analysed and classified by whether calibration methods were reported and if so, the methods used. The review process yielded 154 articles that met our inclusion criteria and, of these, we concluded that 131 may have used calibration methods to determine model parameters. Although the term 'calibration' was not always used, descriptions of calibration or 'model fitting' were found in 50% (n = 66) of the articles, with an additional 16% (n = 21) providing a reference to methods. Calibration target data were identified in nearly all of these articles. Other methodological details, such as the goodness-of-fit metric, were discussed in 54% (n = 47 of 87) of the articles reporting calibration methods, while few details were provided on the algorithms used to search the parameter space. Our review shows that the use of cancer simulation modelling is increasing, although thorough descriptions of calibration procedures are rare in the published literature for these models. Calibration is a key component of model development and is central to the validity and credibility of subsequent analyses and inferences drawn from model predictions. To aid peer-review and facilitate discussion of modelling methods, we propose a standardized Calibration Reporting Checklist for model documentation. [PUBLICATION ABSTRACT] |
Audience | Academic |
Author | Stout, Natasha K. Gazelle, G. Scott Knudsen, Amy B. Kong, Chung Yin McMahon, Pamela M. |
AuthorAffiliation | 1 Department of Ambulatory Care and Prevention, Harvard Medical School/Harvard Pilgrim Health Care, Boston, MA 3 Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA 4 Department of Radiology, Massachusetts General Hospital, Boston, MA 2 Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA |
AuthorAffiliation_xml | – name: 4 Department of Radiology, Massachusetts General Hospital, Boston, MA – name: 2 Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA – name: 1 Department of Ambulatory Care and Prevention, Harvard Medical School/Harvard Pilgrim Health Care, Boston, MA – name: 3 Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA |
Author_xml | – sequence: 1 givenname: Natasha K. surname: Stout fullname: Stout, Natasha K. email: natasha_stout@hms.harvard.edu organization: Department of Ambulatory Care and Prevention, Harvard Medical School/Harvard Pilgrim Health Care, Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health – sequence: 2 givenname: Amy B. surname: Knudsen fullname: Knudsen, Amy B. organization: Institute for Technology Assessment, Massachusetts General Hospital, Department of Radiology, Massachusetts General Hospital – sequence: 3 givenname: Chung Yin surname: Kong fullname: Kong, Chung Yin organization: Institute for Technology Assessment, Massachusetts General Hospital, Department of Radiology, Massachusetts General Hospital – sequence: 4 givenname: Pamela M. surname: McMahon fullname: McMahon, Pamela M. organization: Institute for Technology Assessment, Massachusetts General Hospital, Department of Radiology, Massachusetts General Hospital – sequence: 5 givenname: G. Scott surname: Gazelle fullname: Gazelle, G. Scott organization: Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Institute for Technology Assessment, Massachusetts General Hospital, Department of Radiology, Massachusetts General Hospital |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21921981$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19663525$$D View this record in MEDLINE/PubMed http://econpapers.repec.org/article/wkhphecon/v_3a27_3ay_3a2009_3ai_3a7_3ap_3a533-545.htm$$DView record in RePEc |
BookMark | eNqFUstu1DAUjVARbQd-AUVIsEvxI7bjDVI1ggIqQqIglpbHcTIuiZ3aSVH_njvNTIBu6tjxlX3O8X2dZkc-eJtlOUZnBHP2FmOKy4qiAh3GbD3JTjAWsiCIiKN7GxWCS3ScnaZ0DQBOBXmWHWPJOWWEnWQ_17pzm6hHF3z-xY7bUKf8R7J17ny-1t7YmF-5fur2iFDbLuXa1_nV1LY2jYD8ZocQR-fb_GJycO-8Tc-zp43ukn2x31fZ1Yf339cfi8uvF5_W55eF4RSPhZWlKTViBjUbVhnOKtkwIZDWhpeVpMRazk0lN5tyF69EhlaoxtIQIZmmq-zdrDpMm97Wxvox6k4N0fU63qmgnfr_xrutasOtIqISZclB4M1eIIabCcJRvUvGdp32NkxJccEEqzAF4KsHwOswRQ-hKQKj4hi8XWVnM6jVnVXONwEeNfDVtncGStg4OD8nSFREYlwC4fNMiHawZvH796_tsLVAULeKaiLgd7czEJKwOVi7owEWo1Sxkqnt2IPYy3-Tsagdig2A13uATkZ3TYTyurTgCJYwIdglqyaGlKJtlHHjff0hHNcpjNSuC9WhC9XShbMFAtUDgcWXx6lypiag-NbGv3l-lPsHJTruVg |
CitedBy_id | crossref_primary_10_1007_s40258_013_0012_6 crossref_primary_10_1371_journal_pcbi_1003968 crossref_primary_10_1016_j_jval_2012_04_012 crossref_primary_10_1177_0272989X231184175 crossref_primary_10_1177_0272989X12454579 crossref_primary_10_1016_j_health_2024_100360 crossref_primary_10_1007_s40273_023_01341_z crossref_primary_10_1016_j_drugpo_2020_102726 crossref_primary_10_1016_j_jval_2017_11_010 crossref_primary_10_1001_jamanetworkopen_2018_7621 crossref_primary_10_1371_journal_pcbi_1007893 crossref_primary_10_1155_2014_748750 crossref_primary_10_1038_bjc_2017_407 crossref_primary_10_1016_j_eng_2020_07_018 crossref_primary_10_1007_s40273_015_0335_2 crossref_primary_10_1186_s12911_020_01232_9 crossref_primary_10_1186_1472_6947_13_S2_S7 crossref_primary_10_1038_pcan_2011_27 crossref_primary_10_1200_JOP_2011_000315 crossref_primary_10_1148_radiol_2533091286 crossref_primary_10_1177_0272989X15622642 crossref_primary_10_2165_11584600_000000000_00000 crossref_primary_10_3233_JAD_150233 crossref_primary_10_3390_cancers13081884 crossref_primary_10_1080_14737167_2017_1277143 crossref_primary_10_1038_s41598_017_17215_2 crossref_primary_10_1177_0272989X13487947 crossref_primary_10_1186_s13012_016_0517_0 crossref_primary_10_2165_11593360_000000000_00000 crossref_primary_10_1016_j_jval_2011_01_002 crossref_primary_10_1111_j_1524_4733_2010_00698_x crossref_primary_10_3111_13696998_2013_811080 crossref_primary_10_1098_rsos_231003 crossref_primary_10_1093_jbi_wbaf003 crossref_primary_10_1177_0272989X19889356 crossref_primary_10_1016_j_clinsp_2022_100080 crossref_primary_10_1001_jamanetworkopen_2023_14925 crossref_primary_10_1007_BF03256774 crossref_primary_10_1177_0272989X14551755 crossref_primary_10_3389_fphys_2022_780917 crossref_primary_10_1177_0272989X211009161 crossref_primary_10_1371_journal_pone_0177068 crossref_primary_10_1016_j_jval_2021_10_008 crossref_primary_10_1093_aje_kwu159 crossref_primary_10_1186_1471_2458_10_710 crossref_primary_10_1016_j_acra_2018_10_014 crossref_primary_10_1093_aje_kwaa218 crossref_primary_10_1177_0272989X18792283 crossref_primary_10_2165_11316900_000000000_00000 crossref_primary_10_1007_s40273_017_0494_4 crossref_primary_10_1186_s13195_014_0079_9 crossref_primary_10_1002_cncr_31549 crossref_primary_10_1158_1055_9965_EPI_13_1233 crossref_primary_10_17269_s41997_018_0109_7 crossref_primary_10_1002_sim_8833 crossref_primary_10_1186_s12963_015_0053_1 crossref_primary_10_1002_lary_30270 crossref_primary_10_1186_1471_2288_12_168 crossref_primary_10_1177_0272989X15611359 crossref_primary_10_1016_j_jval_2021_03_005 crossref_primary_10_1093_jnci_djw281 crossref_primary_10_1177_0272989X241258224 crossref_primary_10_1177_0272989X19862560 crossref_primary_10_1177_0272989X14528382 crossref_primary_10_1148_radiol_14141282 crossref_primary_10_1016_j_jcpo_2017_12_006 crossref_primary_10_1177_0272989X13518272 crossref_primary_10_1371_journal_pntd_0008033 crossref_primary_10_1177_0272989X12470755 crossref_primary_10_1007_s10287_018_0329_6 crossref_primary_10_1007_s40273_019_00837_x crossref_primary_10_1371_journal_pone_0083389 crossref_primary_10_1186_s12913_024_11189_4 crossref_primary_10_1007_s10654_014_9978_0 crossref_primary_10_1016_j_drugalcdep_2022_109478 crossref_primary_10_1088_1361_6560_aad105 crossref_primary_10_1177_0272989X16686559 crossref_primary_10_4137_CIN_S38122 crossref_primary_10_6061_clinics_2018_e385 crossref_primary_10_1177_0272989X16636851 crossref_primary_10_1007_s40273_015_0254_2 crossref_primary_10_1007_s40273_021_01125_3 crossref_primary_10_1016_j_vhri_2018_01_002 crossref_primary_10_1007_s10620_013_2705_y crossref_primary_10_1007_s11912_017_0599_0 crossref_primary_10_1177_0272989X10391809 crossref_primary_10_1038_bjc_2015_167 |
Cites_doi | 10.1002/1097-0142(19930901)72:5<1573::AID-CNCR2820720514>3.0.CO;2-9 10.1001/jama.289.3.313 10.1289/ehp.94102s867 10.1016/S0959-8049(00)00330-0 10.1001/jama.1994.03520100035030 10.1159/000331346 10.1136/bmj.297.6649.650 10.1002/ijc.2910430617 10.1158/1055-9965.EPI-05-0223 10.1056/NEJMoa035419 10.1093/jnci/djh104 10.1093/jnci/94.19.1469 10.1016/0895-7177(92)90108-W 10.1093/jnci/91.12.1033 10.1046/j.1524-4733.2003.00003.x 10.2188/jea.7.135 10.1001/jama.295.20.2374 10.1016/S0002-9343(03)00095-0 10.1038/sj.bjc.6603105 10.1016/j.urology.2005.05.030 10.1002/1097-0142(20010915)92:6<1531::AID-CNCR1479>3.0.CO;2-P 10.1093/jncimonographs/lgj012 10.1002/(SICI)1099-1050(199802)7:1<21::AID-HEC306>3.0.CO;2-9 10.1001/jama.284.11.1399 10.1093/jncimonographs/lgj013 10.1016/0168-8510(95)00720-D 10.1191/0962280204sm380ra 10.1016/j.compbiomed.2003.12.006 10.1016/0360-3016(90)90213-4 10.1159/000334021 10.1002/cncr.20392 10.1056/NEJMoa050518 10.1111/j.1572-0241.2000.02172.x 10.1093/geronj/47.2.B32 10.1001/jama.285.24.3107 10.1001/archinte.164.3.245 10.1038/bjc.1985.222 10.1111/j.1524-4733.2008.00484.x 10.1287/ijoc.2.1.4 10.1158/1055-9965.EPI-07-2539 10.1023/A:1019046619402 10.1016/0168-8510(96)00843-3 10.1111/j.1464-410X.2003.4409x.x 10.1016/0377-2217(87)90105-6 10.1111/j.1945-1474.2004.tb00534.x 10.1016/S0169-5002(00)00239-7 10.1002/ijc.22158 10.1158/1055-9965.EPI-04-0411 10.1016/S0959-8049(01)00057-0 10.1016/j.vaccine.2006.05.112 10.1002/1097-0142(19910415)67:8<2021::AID-CNCR2820670802>3.0.CO;2-L 10.1002/ijc.11334 10.1136/bmj.317.7155.376 10.1259/0007-1285-68-806-141 10.1093/jnci/94.3.193 10.1093/ije/26.6.1172 10.1016/S0720-048X(96)01054-6 10.1093/oxfordjournals.aje.a010143 10.1097/00130404-200405000-00005 10.1097/00005392-199909010-00032 10.1007/978-1-4613-1677-0 10.1038/bjc.1990.202 10.1016/0277-9536(90)90294-3 10.1007/BF00051652 10.1093/comjnl/7.4.308 10.1097/01.AOG.0000196500.50044.ce 10.1002/(SICI)1099-1050(199802)7:1<9::AID-HEC304>3.0.CO;2-H 10.2307/2531955 10.1136/jms.8.1.39 10.1200/JCO.2004.05.009 10.1093/jnci/95.12.868 10.1159/000331553 10.1093/jncimonographs/lgj007 10.1097/00130747-200302000-00003 10.1002/sim.2550 10.1097/00130747-200302000-00002 10.1023/A:1011886010184 10.1002/ijc.20846 10.1287/ijoc.1.3.190 10.1023/A:1020326005465 10.1259/bjr/64009424 10.1097/00005650-199212000-00001 10.1016/j.cdp.2004.08.003 10.1017/S0266462304001321 10.1056/NEJMsa044278 10.1093/jnci/92.7.557 10.2307/2532654 10.1002/ijc.21560 10.1053/j.gastro.2004.02.016 10.1016/0895-4356(94)90029-9 10.1258/096914106776179782 10.1093/aje/kwm086 10.1016/S0197-2456(96)00233-4 10.1002/1097-0142(19901001)66:7<1601::AID-CNCR2820660727>3.0.CO;2-O 10.1016/S0025-5564(01)00054-2 10.1002/ijc.2910490410 10.1038/bjc.1985.78 10.1016/S0010-4825(03)00003-9 10.1001/archinte.159.2.142 10.1007/BF01806982 10.1097/00008469-200302000-00012 10.1016/0378-5122(85)90030-1 10.1002/sim.1365 10.1002/ijc.2910460211 10.1093/biostatistics/kxi030 10.1093/jncimonographs/lgj006 10.1006/cbmr.1998.1498 10.1111/j.1541-0420.2005.00363.x 10.1046/j.1524-4733.2003.00234.x 10.1093/jncimonographs/lgj008 10.1001/jama.287.18.2372 10.1093/jncimonographs/lgj010 10.1258/096914106776179809 10.1002/1097-0142(19870901)60:5<1117::AID-CNCR2820600533>3.0.CO;2-H 10.1001/jama.287.18.2382 10.1093/jnci/80.5.337 10.1016/0959-8049(95)94001-F 10.1016/S0889-8588(05)70319-1 10.1093/jncimonographs/lgj011 10.1038/bjc.1989.236 10.1093/annonc/mdl023 10.1111/j.1753-6405.1993.tb00103.x 10.1002/ijc.21513 10.1126/science.220.4598.671 10.1002/sim.1277 10.1002/sim.2178 10.1136/jmg.40.7.e83 10.1093/jnci/87.16.1217 10.1093/jnci/djj210 10.1002/sim.2257 10.1017/S0266462300102077 10.1007/BF00056207 10.1191/0962280204sm376ra 10.1093/oxfordjournals.jncimonographs.a003471 10.1136/jech.40.2.143 10.1136/bmj.318.7180.356 10.2165/00019053-200624110-00002 10.1093/jncimonographs/lgj009 10.1186/1478-7954-5-11 10.1093/imammb/12.3-4.355 10.1111/j.1349-7006.1992.tb00096.x 10.1001/jama.284.15.1954 10.1016/S0002-9343(01)00977-9 10.1093/pubmed/fdh138 10.1093/jnci/94.13.981 10.1198/016214501753168145 10.1038/sj.bjc.6601884 10.1016/0895-4356(91)90075-K 10.1258/096914103769011067 10.1136/jech.36.1.1 10.1200/JCO.2006.07.9202 10.1097/01.AOG.0000120143.50098.c7 10.1136/jms.5.2.81 10.1259/bjr.70.834.9227256 10.3310/hta10080 10.1038/sj.bjc.6601969 10.3310/hta7060 10.1177/096914139600300112 10.7326/0003-4819-113-3-214 10.7326/0003-4819-111-5-389 10.1148/radiology.212.2.r99au49551 10.1136/jms.6.3.132 10.1093/oxfordjournals.aje.a010166 10.1177/096914130301000310 10.7326/0003-4819-115-10-807 10.7326/0003-4819-135-9-200111060-00007 10.7326/0003-4819-130-2-199901190-00003 |
ContentType | Journal Article |
Copyright | Adis Data Information BV 2009 2009 INIST-CNRS COPYRIGHT 2009 Wolters Kluwer Health, Inc. Copyright Wolters Kluwer Health Adis International Jul 2009 |
Copyright_xml | – notice: Adis Data Information BV 2009 – notice: 2009 INIST-CNRS – notice: COPYRIGHT 2009 Wolters Kluwer Health, Inc. – notice: Copyright Wolters Kluwer Health Adis International Jul 2009 |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM DKI X2L 3V. 4T- 7WY 7WZ 7X7 7XB 87Z 88C 88E 88G 8C1 8FI 8FJ 8FK 8FL ABUWG AFKRA AZQEC BENPR BEZIV CCPQU DWQXO FRNLG FYUFA F~G GHDGH GNUQQ K60 K6~ K9. L.- L.0 M0C M0S M0T M1P M2M PHGZM PHGZT PJZUB PKEHL PPXIY PQBIZ PQBZA PQEST PQQKQ PQUKI PSYQQ Q9U 7X8 5PM |
DOI | 10.2165/11314830-000000000-00000 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed RePEc IDEAS RePEc ProQuest Central (Corporate) Docstoc ABI/INFORM Collection ABI/INFORM Global (PDF only) Health & Medical Collection ProQuest Central (purchase pre-March 2016) ABI/INFORM Collection Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) Psychology Database (Alumni) Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ABI/INFORM Collection (Alumni) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central Business Premium Collection ProQuest One Community College ProQuest Central Korea Business Premium Collection (Alumni) Health Research Premium Collection ABI/INFORM Global (Corporate) Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Business Collection (Alumni Edition) ProQuest Business Collection ProQuest Health & Medical Complete (Alumni) ABI/INFORM Professional Advanced ABI/INFORM Professional Standard ABI/INFORM Global ProQuest Health & Medical Collection Healthcare Administration Database Proquest Medical Database Psychology Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Business ProQuest One Business (Alumni) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ABI/INFORM Global (Corporate) ProQuest Business Collection (Alumni Edition) ProQuest One Business ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ABI/INFORM Complete ProQuest Central ABI/INFORM Professional Advanced ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ABI/INFORM Professional Standard ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ABI/INFORM Complete (Alumni Edition) Business Premium Collection ABI/INFORM Global ProQuest Public Health ABI/INFORM Global (Alumni Edition) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Health Management ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) ProQuest Business Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition Docstoc ProQuest Health Management (Alumni Edition) ProQuest One Business (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) Business Premium Collection (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic ABI/INFORM Global (Corporate) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: DKI name: RePEc IDEAS url: http://ideas.repec.org/ sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Economics Public Health Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1179-2027 |
EndPage | 545 |
ExternalDocumentID | PMC2787446 1923251551 A207829114 wkhphecon_v_3a27_3ay_3a2009_3ai_3a7_3ap_3a533_545_htm 19663525 21921981 10_2165_11314830_000000000_00000 |
Genre | Journal Article Review Research Support, N.I.H., Extramural |
GeographicLocations | United States |
GeographicLocations_xml | – name: United States |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: R25 CA092203 – fundername: NCI NIH HHS grantid: R25 CA92203 – fundername: NCI NIH HHS grantid: R00 CA126147 – fundername: NCI NIH HHS grantid: K99 CA126147 – fundername: NCI NIH HHS grantid: F32 CA125984 – fundername: PHS HHS grantid: K99 126147 – fundername: NCI NIH HHS grantid: R01 CA097337 – fundername: PHS HHS grantid: R01 97337 |
GroupedDBID | --- -5G -BR -EM 0R~ 0VX 123 199 29O 36B 3V. 4.4 406 53G 6I2 7WY 7X7 88E 8C1 8FI 8FJ 8FL 8R4 8R5 8V8 95. AAAUJ AACDK AADNT AAIAL AAIKX AAJKR AAKAS AANZL AARHV AASML AATNV AAWTL AAYOK AAYQN AAYTO ABAKF ABDZT ABFTV ABIVO ABJNI ABJOX ABKCH ABKMS ABKTR ABOCM ABPLI ABTKH ABTMW ABUWG ABWHX ABXPI ACAOD ACCOQ ACCUX ACDTI ACGFO ACGFS ACHQT ACMJI ACMLO ACOKC ACPIV ACREN ACZOJ ADBBV ADFRT ADFZG ADHHG ADQRH ADRFC ADURQ ADYOE ADZCM ADZKW AEBTG AEFQL AEJHL AEJRE AEMSY AENEX AEOHA AEPYU AESKC AEVLU AEXYK AEYRQ AFALF AFBBN AFKRA AFWTZ AFZKB AGAYW AGDGC AGQEE AGQMX AGRTI AHMBA AHSBF AIAKS AIGIU AILAN AIZAD AJRNO ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMXSW AMYLF AQUVI ASPBG AVWKF AWSVR AXYYD AZFZN AZQEC A~4 BENPR BEZIV BGNMA BPHCQ BVXVI BYPQX CAG CCPQU COF CS3 DCUDU DNIVK DPUIP DU5 DWQXO EBLON EBR EBS EBU EJD EMOBN ESX F5P FERAY FIGPU FLLZZ FNLPD FRNLG FSGXE FYUFA GNUQQ GROUPED_ABI_INFORM_RESEARCH HG6 HMCUK IAO IBB IEA IHR ITC IWAJR J-C J5H JZLTJ K1G K60 K6~ LGEZI LLZTM LOTEE M0C M0T M1P M2M M4Y NADUK NQJWS NU0 NXXTH OAC OPC OVD P2P PQBIZ PQBZA PQQKQ PROAC PSQYO PSYQQ Q2X RIG ROL RSV RZALA SISQX SJYHP SNPRN SNX SOHCF SOJ SPKJE SRMVM SSLCW TEORI TSG U9L UAX UG4 UKHRP UTJUX VDBLX VFIZW W48 WAF YFH YQY Z0Y Z7U ZMTXR ~JE AAYXX ABBRH ABDBE ABFSG ACMFV ACSTC AEZWR AFDZB AFHIU AFOHR AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT ABRTQ IQODW PJZUB PPXIY CGR CUY CVF ECM EIF NPM PMFND AAFGU AAPBV AAYFA ABPTK ABWBT ACBMV ACBRV ACBYP ACIGE ACTTH ACVWB ADMDM AEFTE AEJOU AEPKY AFNRJ AGGBP AHKMG AJDOV ASKOH DKI UPIKM UPOSE X2L Z7X Z82 Z83 Z84 Z87 AEIIB 4T- 7XB 8FK K9. L.- L.0 PKEHL PQEST PQUKI Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c631t-e94c4a05c0fb58c6589f5770aac648932ee66c89bb4483090c380d19c2795a3 |
IEDL.DBID | 7X7 |
ISSN | 1170-7690 |
IngestDate | Thu Aug 21 14:03:10 EDT 2025 Fri Jul 11 00:58:36 EDT 2025 Fri Jul 25 19:54:30 EDT 2025 Tue Jun 10 21:26:20 EDT 2025 Sat Dec 16 05:50:07 EST 2023 Fri May 30 10:59:23 EDT 2025 Mon Jul 21 09:13:40 EDT 2025 Thu Apr 24 23:03:23 EDT 2025 Tue Jul 01 00:59:02 EDT 2025 Fri Feb 21 02:30:28 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | Unobservable Parameter Comparative Effectiveness Research Calibration Protocol Calibration Method Calibration Target Performance evaluation Methodology Health economy Calibration Simulation model Method Malignant tumor Recommendation Public health Cancer |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c631t-e94c4a05c0fb58c6589f5770aac648932ee66c89bb4483090c380d19c2795a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/2787446 |
PMID | 19663525 |
PQID | 222286189 |
PQPubID | 43702 |
PageCount | 13 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2787446 proquest_miscellaneous_67575813 proquest_journals_222286189 gale_infotracacademiconefile_A207829114 repec_primary_wkhphecon_v_3a27_3ay_3a2009_3ai_3a7_3ap_3a533_545_htm pubmed_primary_19663525 pascalfrancis_primary_21921981 crossref_citationtrail_10_2165_11314830_000000000_00000 crossref_primary_10_2165_11314830_000000000_00000 springer_journals_10_2165_11314830_000000000_00000 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2009-01-01 |
PublicationDateYYYYMMDD | 2009-01-01 |
PublicationDate_xml | – month: 01 year: 2009 text: 2009-01-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Cham |
PublicationPlace_xml | – name: Cham – name: Auckland – name: New Zealand |
PublicationSeriesTitle | PharmacoEconomics |
PublicationTitle | PharmacoEconomics |
PublicationTitleAbbrev | Pharmacoeconomics |
PublicationTitleAlternate | Pharmacoeconomics |
PublicationYear | 2009 |
Publisher | Springer International Publishing Adis International Springer Healthcare | Adis Wolters Kluwer Health, Inc Springer Nature B.V |
Publisher_xml | – name: Springer International Publishing – name: Adis International – name: Springer Healthcare | Adis – name: Wolters Kluwer Health, Inc – name: Springer Nature B.V |
References | Hunter, Drake, Shortt (CR51) 2004; 28 Vervoort, Draisma, Fracheboud (CR82) 2004; 91 Flehinger, Kimmel, Melamed (CR150) 1988; 80 Koscielny, Tubiana, Valleron (CR58) 1985; 52 Plevritis (CR69) 2001; 171 Goldie, Kim, Wright (CR89) 2004; 103 Haug, Brenner (CR125) 2005; 14 Parkin, Moss (CR110) 1986; 40 Shen, Zelen (CR74) 2005; 6 Plevritis, Kurian, Sigal (CR70) 2006; 295 Goldberg (CR21) 1989 Mandelblatt, Lawrence, Yi (CR106) 2004; 9 van Oortmarssen, Habbema, van der Maas (CR81) 1990; 66 Baker (CR27) 1998; 1 Krahn, Mahoney, Eckman (CR170) 1994; 272 Goldie, Gaffikin, Goldhaber-Fiebert (CR91) 2005; 353 Goldie, Weinstein, Kuntz (CR87) 1999; 130 Sato, Matunaga, Tsuji (CR112) 1999; 43 Yang, Liao, Chiu (CR142) 2006; 13 Yeh, Kuntz, Ezzati (CR8) 2008; 17 Ramsey, McIntosh, Etzioni (CR1) 2000; 14 Schechter (CR114) 1996; 40 Loeve, Boer, van Oortmarssen (CR131) 1999; 32 Shen, Huang (CR73) 2005; 61 Goldie, Goldhaber-Fiebert, Garnett (CR5) 2006; 24 Koopmanschap, Lubbe, van Oortmarssen (CR103) 1990; 30 Parker, Muston, Melia (CR171) 2006; 94 Radensky, Mango (CR111) 1998; 42 Hanin, Miller, Zorin (CR49) 2006; 36 Clarke, Plevritis, Boer (CR13) 2006; 36 Manton, Stallard (CR62) 1992; 47 Whynes, Neilson, Walker (CR140) 1998; 7 Urban, Drescher, Etzioni (CR10) 1997; 18 Kimmel, Flehinger (CR175) 1991; 47 Vijan, Hwang, Hofer (CR137) 2001; 111 Gustafsson, Adami (CR93) 1990; 61 Glover (CR24) 1989; 1 Mahadevia, Fleisher, Frick (CR153) 2003; 289 Gustafsson, Adami (CR94) 1992; 3 Kirkpatrick, Gelatt, Vecchi (CR17) 1983; 220 Lee, Zelen (CR59) 2006; 36 Sherlaw-Johnson, Gallivan, Jenkins (CR115) 1999; 318 Law, Kelton (CR12) 2000 Knox (CR57) 1988; 297 Gyrd-Hansen, Søgaard, Kronborg (CR124) 1998; 7 Goldie (CR4) 2003; 31 Press, Teukolsky, Vetterling (CR18) 2002 Myers, Havrilesky, Kulasingam (CR160) 2006; 145 Khandker, Dulski, Kilpatrick (CR126) 2000; 16 Kim, Kuntz, Stout (CR178) 2007; 166 Eddy (CR85) 1987; 60 van der Maas, de Koning, van Ineveld (CR79) 1989; 43 Mandelblatt, Lawrence, Womack (CR9) 2002; 287 Yamaguchi, Mizuno, Akiba (CR156) 1992; 83 Goldhaber-Fiebert, Stout, Ortendahl (CR179) 2007; 5 Knudsen, McMahon, Gazelle (CR2) 2007; 25 Eddy (CR44) 1989; 111 Wagner, Herdman, Wadhwa (CR138) 1991; 115 Glover (CR25) 1990; 2 Ross, Guess, Carter (CR173) 2005; 66 van Ballegooijen, van den Akker-van Marle, Patnick (CR119) 2000; 36 Michaelson, Satija, Moore (CR65) 2003; 5 Stout, Rosenberg, Trentham-Dietz (CR75) 2006; 98 Cowen, Chartrand, Weitzel (CR163) 1994; 47 Weinstein, O’Brien, Hornberger (CR180) 2003; 6 Fryback, Stout, Rosenberg (CR48) 2006; 36 Gyrd-Hansen, Søgaard, Kronborg (CR123) 1997; 26 Holland (CR20) 1975 van Oortmarssen, Habbema, Lubbe (CR80) 1990; 46 Yamaguchi, Tamura, Sobue (CR155) 1991; 2 Lejeune, Arveux, Dancourt (CR130) 2004; 20 Downer, Jullien, Speight (CR159) 1997; 14 Sherlaw-Johnson, Philips (CR116) 2004; 91 Fendrick, Chernew, Hirth (CR145) 1999; 159 Koong, Yen, Chen (CR102) 2006; 13 Beemsterboer, Warmerdam, Boer (CR29) 1998; 5 Parkin (CR109) 1985; 51 Roderick, Davies, Raftery (CR147) 2003; 10 Szeto, Devlin (CR76) 1996; 38 Wang, Wang, Chiu (CR176) 2006; 13 Cong, Shen, Miller (CR40) 2005; 24 Paci, Boer, Zappa (CR68) 1995; 31 de Koning, Boer, Warmerdam (CR43) 1995; 87 Girgis, Clarke, Burton (CR158) 1996; 3 Frazier, Colditz, Fuchs (CR122) 2000; 284 Ingber, Rosen (CR23) 1992; 16 Knox, McLachlan (CR101) 1973 Marshall, Simpson, Earle (CR154) 2001; 32 Nelder, Mead (CR16) 1965; 7 Ladabaum, Scheiman, Fendrick (CR128) 2003; 114 de Koning, van Ineveld, van Oortmarssen (CR42) 1991; 21 Plevritis, Sigal, Salzman (CR71) 2006; 36 Tan, van Oortmarssen, de Koning (CR77) 2006; 36 Feldstein, Zelen (CR45) 1984; 4 van den Akker-van Marle, van Ballegooijen, van Oortmarssen (CR120) 2002; 94 Boer, de Koning, van Oortmarssen (CR34) 1999; 6 Neilson, Whynes (CR134) 1995; 12 Goldie, Grima, Kohli (CR7) 2003; 106 Kim, Leung, Woo (CR100) 2004; 26 Ladabaum, Chopra, Huang (CR127) 2001; 135 Habbema, van Oortmarssen, Lubbe (CR96) 1985; 7 Fracheboud, Groenewoud, Boer (CR47) 2006; 118 Goldie, Kohli, Grima (CR90) 2004; 96 Lejeune, Arveux, Dancourt (CR129) 2003; 12 Draisma, De Koning (CR165) 2003; 92 Davies, Crabbe, Roderick (CR144) 2002; 5 Jansen, Zoetelief (CR54) 1995; 68 Skates, Singer (CR161) 1991; 44 Feuer, Etzioni, Cronin (CR3) 2004; 13 Beckett, Kotre, Michaelson (CR28) 2003; 76 Habbema, Lubbe, van Oortmarssen (CR97) 1987; 29 Sawaya, McConnell, Kulasingam (CR113) 2003; 349 Draisma, Boer, Otto (CR164) 2003; 95 Eddy (CR86) 1990; 113 Gorlova, Kimmel, Henschke (CR152) 2001; 92 Mandelblatt, Schechter, Lawrence (CR61) 2006; 36 Berry, Inoue, Shen (CR31) 2006; 36 Jansen, Zoetelief (CR56) 1997; 24 Berkhof, de Bruijne, Zielinski (CR84) 2006; 118 Berry, Cronin, Plevritis (CR30) 2005; 353 Jacobi, Nagelkerke, van Houwelingen (CR53) 2006; 15 Sreenivas, Prabhakar, Ravi (CR118) 1989; 36 Carter, Castro, Kessler (CR37) 2004; 26 Fett (CR46) 2001; 8 Jansen, Zoetelief (CR55) 1997; 70 Okubo, Glick, Frumkin (CR67) 1991; 67 Connor, Boer, Prorok (CR41) 2000; 151 Roderick, Davies, Raftery (CR146) 2003; 7 Chia, Salzman, Plevritis (CR39) 2004; 13 Helfand, O’Connor, Zimmer-Gembeck (CR98) 1992; 30 Flehinger, Kimmel, Polyak (CR151) 1993; 72 Myers, McCrory, Nanda (CR11) 2000; 151 Michaelson, Halpern, Kopans (CR63) 1999; 212 Gustafsson, Adami (CR92) 1989; 60 Kulasingam, Myers, Lawson (CR104) 2006; 107 Ross, Carter, Pearson (CR172) 2000; 284 Etzioni, Cha, Cowen (CR167) 1999; 162 Castro, Carter, Kessler (CR38) 2005; 35 Jacobi, Jonker, Nagelkerke (CR52) 2003; 40 Matsunaga, Tsuji, Sato (CR107) 1997; 7 Flehinger, Kimmel (CR149) 1987; 43 Michaelson, Satija, Moore (CR64) 2003; 5 Clemen, Lacke (CR121) 2001; 4 Hsieh, Chen, Chang (CR50) 2002; 21 Berkhof, de Bruijne, Zielinski (CR83) 2005; 115 Loeve, Brown, Boer (CR132) 2000; 92 Weinstein (CR6) 2006; 24 Wong, Yen, Lai (CR141) 2004; 10 Tsodikov, Szabo, Wegelin (CR174) 2006; 25 Bruning, Kintz (CR15) 1997 Blanchard, Colbert, Puri (CR32) 2004; 101 Shun-Zhang, Miller, Sherman (CR117) 1982; 36 Goldie, Kuhn, Denny (CR88) 2001; 285 Gyrd-Hansen, Holund, Andersen (CR95) 1995; 34 Garside, Pitt, Somerville (CR143) 2006; 10 Banks (CR14) 1998 Draisma, Postma, Schroder (CR166) 2006; 119 Yamaguchi, Tamura, Sobue (CR157) 1994; 102 Etzioni, Penson, Legler (CR169) 2002; 94 Ness, Holmes, Klein (CR135) 2000; 95 Kim, Wright, Goldie (CR99) 2002; 287 Song, Fendrick, Ladabaum (CR136) 2004; 126 Mandelblatt, Lawrence, Gaffikin (CR105) 2002; 94 Etzioni, Legler, Feuer (CR168) 1999; 91 Loeve, Boer, van Oortmarssen (CR133) 2001; 37 Mandelblatt, Schechter, Yabroff (CR60) 2004; 22 Carter, Glasziou, van Oortmarssen (CR35) 1993; 17 Wagner, Tunis, Brown, Young, Rosen, Levin (CR139) 1996 Manikas, Cain (CR22) 1996 Garrison (CR177) 2003; 6 Tubiana, Koscielny (CR78) 1990; 19 Kong, McMahon, Gazelle (CR26) 2009; 12 Skates, Pauler, Jacobs (CR162) 2001; 96 Boer, de Koning, Threlfall (CR33) 1998; 317 Myles, Nixon, Duffy (CR66) 2003; 22 (CR108) 1990 Das, Ng, Earle (CR148) 2006; 17 Wong, Leong, Liu (CR19) 1988 Carter, Castro, Kessler (CR36) 2003; 33 Plevritis, Salzman, Sigal (CR72) 2006; 26 Frazier (R122-2-20090810) 2000 Oct 18; 284 Vijan (R137-2-20090810) 2001 Dec 1; 111 Lejeune (R129-2-20090810) 2003 Feb; 12 Whynes (R140-2-20090810) 1998 Feb; 7 Goldie (R87-2-20090810) 1999 Jan 19; 130 (R108-2) 1990 Wong (R19-2) 1988 Carter (R35-2-20090810) 1993 Mar; 17 Roderick (R146-2-20090810) 2003; 7 Fett (R46-2-20090810) 2001; 8 Marshall (R154-2-20090810) 2001 Jun; 32 Sato (R112-2-20090810) 1999 Nov-Dec; 43 Gyrd-Hansen (R123-2-20090810) 1997 Dec; 26 Flehinger (R151-2-20090810) 1993 Sep 1; 72 Urban (R10-2-20090810) 1997 Jun; 18 Cong (R40-2-20090810) 2005 Oct 30; 24 Michaelson (R65-2-20090810) 2003 Feb; 5 Okubo (R67-2-20090810) 1991 Apr 15; 67 Skates (R161-2-20090810) 1991; 44 Tubiana (R78-2-20090810) 1990 Nov; 19 Plevritis (R69-2-20090810) 2001 Jun; 171 Jansen (R54-2-20090810) 1995 Feb; 68 Myers (R11-2-20090810) 2000 June 15, 2000; 151 Yamaguchi (R156-2-20090810) 1992 Mar; 83 Beemsterboer (R29-2-20090810) 1998; 5 Clemen (R121-2-20090810) 2001 Dec; 4 Song (R136-2-20090810) 2004 May; 126 Roderick (R147-2-20090810) 2003; 10 Gustafsson (R94-2-20090810) 1992 Mar; 3 Neilson (R134-2-20090810) 1995 Sep-Dec; 12 Weinstein (R180-2-20090810) 2003 Jan-Feb; 6 Press (R18-2) 2002 Vervoort (R82-2-20090810) 2004 Jul 19; 91 Wagner (R138-2-20090810) 1991 Nov 15; 115 Hanin (R49-2-20090810) 2006; 36 Shun-Zhang (R117-2-20090810) 1982 Mar; 36 Haug (R125-2-20090810) 2005 Feb; 14 Berkhof (R84-2-20090810) 2006 Apr 1; 118 Loeve (R131-2-20090810) 1999 Feb; 32 Goldie (R90-2-20090810) 2004 Apr 21; 96 Loeve (R133-2-20090810) 2001 May; 37 Jacobi (R53-2-20090810) 2006 Mar; 15 Gustafsson (R93-2-20090810) 1990 Jun; 61 Weinstein (R6-2-20090810) 2006; 24 Glover (R24-2-20090810) 1989; 1 Goldie (R7-2-20090810) 2003; 106 Hunter (R51-2-20090810) 2004; 28 Michaelson (R64-2-20090810) 2003 Feb; 5 Helfand (R98-2-20090810) 1992 Dec; 30 Ladabaum (R128-2-20090810) 2003 May; 114 Etzioni (R169-2-20090810) 2002 Jul 3; 94 Hsieh (R50-2-20090810) 2002 Nov 30; 21 Mandelblatt (R105-2-20090810) 2002 Oct 2; 94 Kim (R99-2-20090810) 2002 May 8; 287 Holland (R20-2) 1975 Sherlaw-Johnson (R115-2-20090810) 1999 Feb 6; 318 Ladabaum (R127-2-20090810) 2001 Nov 6; 135 Goldie (R4-2-20090810) 2003; 31 Szeto (R76-2-20090810) 1996 Nov; 38 Plevritis (R71-2-20090810) 2006; 36 Koong (R102-2-20090810) 2006; 13 Law (R12-2) 2000 Wagner (R139-2) 1996 Goldie (R89-2-20090810) 2004 Apr; 103 Kim (R178-2-20090810) 2007 July 15, 2007; 166 Mandelblatt (R9-2-20090810) 2002 May 8; 287 Clarke (R13-2-20090810) 2006; 36 Radensky (R111-2-20090810) 1998 Jan-Feb; 42 Goldberg (R21-2) 1989 Yamaguchi (R155-2-20090810) 1991 May; 2 Ross (R173-2-20090810) 2005 Nov; 66 Tan (R77-2-20090810) 2006; 36 Glover (R25-2-20090810) 1990; 2 Gorlova (R152-2-20090810) 2001 Sep 15; 92 Parker (R171-2-20090810) 2006 May 22; 94 de Koning (R42-2-20090810) 1991 Oct 21; 49 Draisma (R164-2-20090810) 2003 Jun 18; 95 Draisma (R165-2-20090810) 2003 Dec; 92 Mandelblatt (R61-2-20090810) 2006; 36 Yeh (R8-2-20090810) 2008 May 1; 17 Ross (R172-2-20090810) 2000 Sep 20; 284 Garside (R143-2-20090810) 2006 Mar; 10 Plevritis (R72-2-20090810) 2006; 26 van den Akker-van Marle (R120-2-20090810) 2002 Feb 6; 94 Michaelson (R63-2-20090810) 1999 Aug; 212 Fendrick (R145-2-20090810) 1999 Jan 25; 159 Knox (R101-2) 1973 Downer (R159-2-20090810) 1997 Dec; 14 Boer (R34-2-20090810) 1999; 6 Castro (R38-2-20090810) 2005 Feb; 35 Gyrd-Hansen (R95-2-20090810) 1995 Oct; 34 Knudsen (R2-2-20090810) 2007; 25 Bruning (R15-2) 1997 Goldie (R88-2-20090810) 2001 Jun 27; 285 Cowen (R163-2-20090810) 1994 Jan; 47 Goldie (R5-2-20090810) 2006 Aug 31; 24 Yamaguchi (R157-2-20090810) 1994 Nov; 102 Baker (R27-2-20090810) 1998 Oct; 1 Berry (R30-2-20090810) 2005 Oct 27; 353 Habbema (R97-2-20090810) 1987 May; 29 Khandker (R126-2-20090810) 2000 Summer; 16 Berkhof (R83-2-20090810) 2005 Jun 10; 115 Fryback (R48-2-20090810) 2006; 36 Feuer (R3-2-20090810) 2004 Dec; 13 Carter (R36-2-20090810) 2003 Jul; 33 Paci (R68-2-20090810) 1995; 31A Boer (R33-2-20090810) 1998 Aug 8; 317 Das (R148-2-20090810) 2006 May; 17 Blanchard (R32-2-20090810) 2004 Aug 1; 101 Lee (R59-2-20090810) 2006; 36 Parkin (R110-2-20090810) 1986 Jun; 40 Jansen (R56-2-20090810) 1997 Feb; 24 Flehinger (R150-2-20090810) 1988 May 4; 80 Draisma (R166-2-20090810) 2006 Nov 15; 119 Habbema (R96-2-20090810) 1985 May; 7 Krahn (R170-2-20090810) 1994 Sep 14; 272 Loeve (R132-2-20090810) 2000 Apr 5; 92 Skates (R162-2-20090810) 2001; 96 van Oortmarssen (R80-2-20090810) 1990 Aug 15; 46 Gustafsson (R92-2-20090810) 1989 Jul; 60 Matsunaga (R107-2-20090810) 1997 Sep; 7 Sherlaw-Johnson (R116-2-20090810) 2004 Jul 5; 91 Kim (R100-2-20090810) 2004 Jun; 26 Mandelblatt (R106-2-20090810) 2004 Feb 9; 164 Shen (R74-2-20090810) 2005 Oct; 6 Girgis (R158-2-20090810) 1996; 3 Kulasingam (R104-2-20090810) 2006 Feb; 107 Eddy (R85-2-20090810) 1987 Sep 1; 60 Tsodikov (R174-2-20090810) 2006 Aug 30; 25 Manikas (R22-2) 1996 Fracheboud (R47-2-20090810) 2006 Apr 15; 118 Eddy (R86-2-20090810) 1990 Aug 1; 113 Eddy (R44-2-20090810) 1989; 111 Yang (R142-2-20090810) 2006; 13 Goldie (R91-2-20090810) 2005 Nov 17; 353 Manton (R62-2-20090810) 1992 Nov; 47 Spec No Etzioni (R168-2-20090810) 1999 Jun 16; 91 Gyrd-Hansen (R124-2-20090810) 1998 Feb; 7 Chia (R39-2-20090810) 2004 Dec; 13 Flehinger (R149-2-20090810) 1987 Mar; 43 van der Maas (R79-2-20090810) 1989 Jun 15; 43 Beckett (R28-2-20090810) 2003 May; 76 Berry (R31-2-20090810) 2006; 36 de Koning (R43-2-20090810) 1995 Aug 16; 87 Etzioni (R167-2-20090810) 1999 Sep; 162 Garrison (R177-2-20090810) 2003 Jan-Feb; 6 Kong (R26-2-20090810) 2009; 12 Mandelblatt (R60-2-20090810) 2004 Jul 1; 22 Sawaya (R113-2-20090810) 2003 Oct 16; 349 Wang (R176-2-20090810) 2006; 13 Connor (R41-2-20090810) 2000 May 15; 151 Davies (R144-2-20090810) 2002 Nov; 5 Banks (R14-2) 1998 Myles (R66-2-20090810) 2003 May 30; 22 van Ballegooijen (R119-2-20090810) 2000 Nov; 36 Jansen (R55-2-20090810) 1997 Jun; 70 Knox (R57-2-20090810) 1988 Sep 10; 297 Parkin (R109-2-20090810) 1985 Apr; 51 Lejeune (R130-2-20090810) 2004 Fall; 20 Kimmel (R175-2-20090810) 1991 Sep; 47 Ramsey (R1-2-20090810) 2000 Aug; 14 Ingber (R23-2-20090810) 1992; 16 Koscielny (R58-2-20090810) 1985 Oct; 52 Feldstein (R45-2-20090810) 1984; 4 Schechter (R114-2-20090810) 1996 Nov-Dec; 40 Nelder (R16-2-20090810) 1965; 7 Jacobi (R52-2-20090810) 2003 Jul; 40 Ness (R135-2-20090810) 2000 Jul; 95 Koopmanschap (R103-2-20090810) 1990; 30 Shen (R73-2-20090810) 2005 Dec; 61 Mahadevia (R153-2-20090810) 2003 Jan 15; 289 Plevritis (R70-2-20090810) 2006 May 24; 295 Wong (R141-2-20090810) 2004 May-Jun; 10 van Oortmarssen (R81-2-20090810) 1990 Oct 1; 66 Sreenivas (R118-2-20090810) 1989; 36 Carter (R37-2-20090810) 2004 Nov-Dec; 26 Stout (R75-2-20090810) 2006 Jun 7; 98 Kirkpatrick (R17-2-20090810) 1983; 220 |
References_xml | – volume: 72 start-page: 1573 issue: 5 year: 1993 end-page: 80 ident: CR151 article-title: Screening for lung cancer: the Mayo Lung Project revisited publication-title: Cancer doi: 10.1002/1097-0142(19930901)72:5<1573::AID-CNCR2820720514>3.0.CO;2-9 – volume: 289 start-page: 313 issue: 3 year: 2003 end-page: 22 ident: CR153 article-title: Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis publication-title: JAMA doi: 10.1001/jama.289.3.313 – volume: 102 start-page: 67 issue: 8 year: 1994 end-page: 71 ident: CR157 article-title: Evaluation of cancer prevention strategies by computerized simulation model: methodological issues publication-title: Environ Health Perspect doi: 10.1289/ehp.94102s867 – volume: 36 start-page: 2177 issue: 17 year: 2000 end-page: 88 ident: CR119 article-title: Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness publication-title: Eur J Cancer doi: 10.1016/S0959-8049(00)00330-0 – volume: 272 start-page: 773 issue: 10 year: 1994 end-page: 80 ident: CR170 article-title: Screening for prostate cancer: a decision analytic view publication-title: JAMA doi: 10.1001/jama.1994.03520100035030 – volume: 43 start-page: 1006 issue: 6 year: 1999 end-page: 14 ident: CR112 article-title: Determining the cost-effectiveness of mass screening for cervical cancer using common analytic models publication-title: Acta Cytol doi: 10.1159/000331346 – volume: 297 start-page: 650 issue: 6649 year: 1988 end-page: 4 ident: CR57 article-title: Evaluation of a proposed breast cancer screening regimen publication-title: BMJ doi: 10.1136/bmj.297.6649.650 – volume: 151 start-page: 1158 issue: 12 year: 2000 end-page: 71 ident: CR11 article-title: Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis publication-title: Am J Epidemiol 2000 June 15 – volume: 43 start-page: 1055 issue: 6 year: 1989 end-page: 60 ident: CR79 article-title: The cost-effectiveness of breast cancer screening publication-title: Int J Cancer doi: 10.1002/ijc.2910430617 – volume: 15 start-page: 429 issue: 3 year: 2006 end-page: 36 ident: CR53 article-title: Breast cancer screening, outside the population-screening program, of women from breast cancer families without proven BRCA1/BRCA2 mutations: a simulation study publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-05-0223 – volume: 349 start-page: 1501 issue: 16 year: 2003 end-page: 9 ident: CR113 article-title: Risk of cervical cancer associated with extending the interval between cervical-cancer screenings publication-title: N Engl J Med doi: 10.1056/NEJMoa035419 – volume: 96 start-page: 604 issue: 8 year: 2004 end-page: 15 ident: CR90 article-title: Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djh104 – volume: 94 start-page: 1469 issue: 19 year: 2002 end-page: 83 ident: CR105 article-title: Costs and benefits of different strategies to screen for cervical cancer in less-developed countries publication-title: J Natl Cancer Inst doi: 10.1093/jnci/94.19.1469 – volume: 16 start-page: 87 issue: 11 year: 1992 end-page: 100 ident: CR23 article-title: Genetic algorithms and very fast simulated annealing: a comparison publication-title: Math Comput Model doi: 10.1016/0895-7177(92)90108-W – volume: 91 start-page: 1033 issue: 12 year: 1999 end-page: 9 ident: CR168 article-title: Cancer surveillance series: interpreting trends in prostate cancer. Part III: quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality publication-title: J Natl Cancer Inst doi: 10.1093/jnci/91.12.1033 – volume: 6 start-page: 6 issue: 1 year: 2003 end-page: 8 ident: CR177 article-title: The ISPOR good practice modeling principles: a sensible approach. Be transparent, be reasonable publication-title: Value Health doi: 10.1046/j.1524-4733.2003.00003.x – year: 2002 ident: CR18 publication-title: Numerical recipes in C++ – volume: 7 start-page: 135 issue: 3 year: 1997 end-page: 41 ident: CR107 article-title: Cost-effective analysis of mass screening for cervical cancer in Japan publication-title: J Epidemiol doi: 10.2188/jea.7.135 – volume: 295 start-page: 2374 issue: 20 year: 2006 end-page: 84 ident: CR70 article-title: Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging publication-title: JAMA doi: 10.1001/jama.295.20.2374 – volume: 114 start-page: 546 issue: 7 year: 2003 end-page: 54 ident: CR128 article-title: Potential effect of cyclooxygenase-2-specific inhibitors on the prevention of colorectal cancer: a cost-effectiveness analysis publication-title: Am J Med doi: 10.1016/S0002-9343(03)00095-0 – volume: 94 start-page: 1361 issue: 10 year: 2006 end-page: 8 ident: CR171 article-title: A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival publication-title: Br J Cancer doi: 10.1038/sj.bjc.6603105 – volume: 66 start-page: 1038 issue: 5 year: 2005 end-page: 42 ident: CR173 article-title: Estimation of treatment benefits when PSA screening for prostate cancer is discontinued at different ages publication-title: Urology doi: 10.1016/j.urology.2005.05.030 – volume: 92 start-page: 1531 issue: 6 year: 2001 end-page: 40 ident: CR152 article-title: Modeling of long-term screening for lung carcinoma publication-title: Cancer doi: 10.1002/1097-0142(20010915)92:6<1531::AID-CNCR1479>3.0.CO;2-P – volume: 36 start-page: 86 year: 2006 end-page: 95 ident: CR71 article-title: A stochastic simulation model of U.S. breast cancer mortality trends from 1975 to 2000 publication-title: J Natl Cancer Inst Monogr doi: 10.1093/jncimonographs/lgj012 – volume: 7 start-page: 21 issue: 1 year: 1998 end-page: 9 ident: CR140 article-title: Faecal occult blood screening for colorectal cancer: is it cost-effective? publication-title: Health Econ doi: 10.1002/(SICI)1099-1050(199802)7:1<21::AID-HEC306>3.0.CO;2-9 – volume: 284 start-page: 1399 issue: 11 year: 2000 end-page: 405 ident: CR172 article-title: Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection publication-title: JAMA doi: 10.1001/jama.284.11.1399 – volume: 36 start-page: 96 year: 2006 end-page: 105 ident: CR13 article-title: A comparative review of CISNET breast models used to analyze U.S. breast cancer incidence and mortality trends publication-title: J Natl Cancer Inst Monogr doi: 10.1093/jncimonographs/lgj013 – volume: 34 start-page: 35 issue: 1 year: 1995 end-page: 51 ident: CR95 article-title: A cost-effectiveness analysis of cervical cancer screening: health policy implications publication-title: Health Policy doi: 10.1016/0168-8510(95)00720-D – volume: 13 start-page: 507 issue: 6 year: 2004 end-page: 24 ident: CR39 article-title: Simulation-based parameter estimation for complex models: a breast cancer natural history modelling illustration publication-title: Stat Methods Med Res doi: 10.1191/0962280204sm380ra – volume: 13 start-page: 44 issue: 1 year: 2006 end-page: 7 ident: CR102 article-title: Efficacy and cost-effectiveness of nationwide cervical cancer screening in Taiwan publication-title: J Med Screen – volume: 35 start-page: 91 issue: 2 year: 2005 end-page: 101 ident: CR38 article-title: The relation of breast cancer staging to screening protocol compliance: a computer simulation study publication-title: Comput Biol Med doi: 10.1016/j.compbiomed.2003.12.006 – volume: 19 start-page: 1117 issue: 5 year: 1990 end-page: 20 ident: CR78 article-title: The natural history of breast cancer: implications for a screening strategy publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/0360-3016(90)90213-4 – volume: 40 start-page: 1272 issue: 6 year: 1996 end-page: 82 ident: CR114 article-title: Cost-effectiveness of rescreening conventionally prepared cervical smears by PAPNET testing publication-title: Acta Cytol doi: 10.1159/000334021 – volume: 101 start-page: 495 issue: 3 year: 2004 end-page: 507 ident: CR32 article-title: Mammographic screening: patterns of use and estimated impact on breast carcinoma survival publication-title: Cancer doi: 10.1002/cncr.20392 – volume: 353 start-page: 1784 issue: 17 year: 2005 end-page: 92 ident: CR30 article-title: Effect of screening and adjuvant treatment on mortality from breast cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa050518 – volume: 36 start-page: 623 issue: 5 year: 1989 end-page: 7 ident: CR118 article-title: A simulation approach for estimating the loss of woman years due to cervical cancer and probability of developing cervical cancer publication-title: Neoplasma – volume: 95 start-page: 1800 issue: 7 year: 2000 end-page: 11 ident: CR135 article-title: Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2000.02172.x – volume: 47 start-page: 32 year: 1992 end-page: 42 ident: CR62 article-title: Demographics (1950–1987) of breast cancer in birth cohorts of older women publication-title: J Gerontol doi: 10.1093/geronj/47.2.B32 – volume: 285 start-page: 3107 issue: 24 year: 2001 end-page: 15 ident: CR88 article-title: Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness publication-title: JAMA doi: 10.1001/jama.285.24.3107 – volume: 9 start-page: 245 issue: 164 year: 2004 end-page: 7 ident: CR106 article-title: The balance of harms, benefits, and costs of screening for cervical cancer in older women publication-title: Arch Intern Med doi: 10.1001/archinte.164.3.245 – volume: 52 start-page: 515 issue: 4 year: 1985 end-page: 24 ident: CR58 article-title: A simulation model of the natural history of human breast cancer publication-title: Br J Cancer doi: 10.1038/bjc.1985.222 – volume: 12 start-page: 521 issue: 4 year: 2009 end-page: 9 ident: CR26 article-title: Calibration of disease simulation models using an engineering approach publication-title: Value Health doi: 10.1111/j.1524-4733.2008.00484.x – volume: 2 start-page: 4 issue: 1 year: 1990 end-page: 32 ident: CR25 article-title: Tabu search: part II publication-title: ORSA J Computing doi: 10.1287/ijoc.2.1.4 – volume: 17 start-page: 1179 issue: 5 year: 2008 end-page: 87 ident: CR8 article-title: Development of an empirically calibrated model of gastric cancer in two high-risk countries publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-07-2539 – volume: 1 start-page: 103 issue: 2 year: 1998 end-page: 13 ident: CR27 article-title: Use of a mathematical model to evaluate breast cancer screening policy publication-title: Health Care Manage Sci doi: 10.1023/A:1019046619402 – volume: 38 start-page: 101 issue: 2 year: 1996 end-page: 15 ident: CR76 article-title: The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand publication-title: Health Policy doi: 10.1016/0168-8510(96)00843-3 – volume: 111 start-page: 389 issue: 5 year: 1989 end-page: 99 ident: CR44 article-title: Screening for breast cancer publication-title: Ann Intern Med – volume: 92 start-page: 106 issue: 2 year: 2003 end-page: 11 ident: CR165 article-title: MISCAN: estimating lead-time and over-detection by simulation publication-title: BJU Int doi: 10.1111/j.1464-410X.2003.4409x.x – volume: 29 start-page: 159 issue: 2 year: 1987 end-page: 66 ident: CR97 article-title: A simulation approach to cost-effectiveness and cost-benefit calculations of screening for the early detection of disease publication-title: Eur J Oper Res doi: 10.1016/0377-2217(87)90105-6 – volume: 26 start-page: 31 issue: 6 year: 2004 end-page: 8 ident: CR37 article-title: Simulation of breast cancer screening: quality assessment of two protocols publication-title: J Healthc Qual doi: 10.1111/j.1945-1474.2004.tb00534.x – volume: 32 start-page: 227 issue: 3 year: 2001 end-page: 36 ident: CR154 article-title: Potential cost-effectiveness of one-time screening for lung cancer (LC) in a high risk cohort publication-title: Lung Cancer doi: 10.1016/S0169-5002(00)00239-7 – volume: 119 start-page: 2366 issue: 10 year: 2006 end-page: 71 ident: CR166 article-title: Gleason score, age and screening: modeling dedifferentiation in prostate cancer publication-title: Int J Cancer doi: 10.1002/ijc.22158 – volume: 14 start-page: 422 issue: 2 year: 2005 end-page: 8 ident: CR125 article-title: A simulation model for colorectal cancer screening: potential of stool tests with various performance characteristics compared with screening colonoscopy publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-04-0411 – volume: 37 start-page: 912 issue: 7 year: 2001 end-page: 7 ident: CR133 article-title: Impact of systematic false-negative test results on the performance of faecal occult blood screening publication-title: Eur J Cancer doi: 10.1016/S0959-8049(01)00057-0 – volume: 24 start-page: 155 issue: 3 year: 2006 end-page: 63 ident: CR5 article-title: Chapter 18: public health policy for cervical cancer prevention. The role of decision science, economic evaluation, and mathematical modeling publication-title: Vaccine doi: 10.1016/j.vaccine.2006.05.112 – volume: 67 start-page: 2021 issue: 8 year: 1991 end-page: 9 ident: CR67 article-title: Cost-effectiveness analysis of mass screening for breast cancer in Japan publication-title: Cancer doi: 10.1002/1097-0142(19910415)67:8<2021::AID-CNCR2820670802>3.0.CO;2-L – volume: 106 start-page: 896 year: 2003 end-page: 904 ident: CR7 article-title: A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine publication-title: Int J Cancer doi: 10.1002/ijc.11334 – volume: 317 start-page: 376 issue: 7155 year: 1998 end-page: 9 ident: CR33 article-title: Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study publication-title: BMJ doi: 10.1136/bmj.317.7155.376 – volume: 68 start-page: 141 issue: 806 year: 1995 end-page: 9 ident: CR54 article-title: MBS: a model for risk benefit analysis of breast cancer screening publication-title: Br J Radiol doi: 10.1259/0007-1285-68-806-141 – volume: 94 start-page: 193 issue: 3 year: 2002 end-page: 204 ident: CR120 article-title: Cost-effectiveness of cervical cancer screening: comparison of screening policies publication-title: J Natl Cancer Inst doi: 10.1093/jnci/94.3.193 – volume: 26 start-page: 1172 issue: 6 year: 1997 end-page: 81 ident: CR123 article-title: Analysis of screening data: colorectal cancer publication-title: Int J Epidemiol doi: 10.1093/ije/26.6.1172 – volume: 24 start-page: 137 issue: 2 year: 1997 end-page: 44 ident: CR56 article-title: Optimisation of mammographic breast cancer screening using a computer simulation model publication-title: Eur J Radiol doi: 10.1016/S0720-048X(96)01054-6 – volume: 151 start-page: 991 issue: 10 year: 2000 end-page: 8 ident: CR41 article-title: Investigation of design and bias issues in case-control studies of cancer screening using microsimulation publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a010143 – volume: 10 start-page: 160 issue: 3 year: 2004 end-page: 9 ident: CR141 article-title: Progression rates of colorectal cancer by Dukes’ stage in a high-risk group: analysis of selective colorectal cancer screening publication-title: Cancer J doi: 10.1097/00130404-200405000-00005 – volume: 162 start-page: 741 issue: 3 year: 1999 end-page: 8 ident: CR167 article-title: Serial prostate specific antigen screening for prostate cancer: a computer model evaluates competing strategies publication-title: J Urol doi: 10.1097/00005392-199909010-00032 – year: 1988 ident: CR19 publication-title: Simulated annealing for VLSI design doi: 10.1007/978-1-4613-1677-0 – volume: 70 start-page: 619 issue: 834 year: 1997 end-page: 28 ident: CR55 article-title: Assessment of lifetime gained as a result of mammographic breast cancer screening using a computer model publication-title: Br J Radiol – year: 1989 ident: CR21 publication-title: Genetic algorithms in search, optimization and machine learning – volume: 61 start-page: 903 issue: 6 year: 1990 end-page: 8 ident: CR93 article-title: Cytologic screening for cancer of the uterine cervix in Sweden evaluated by identification and simulation publication-title: Br J Cancer doi: 10.1038/bjc.1990.202 – volume: 30 start-page: 1081 issue: 10 year: 1990 end-page: 7 ident: CR103 article-title: Economic aspects of cervical cancer screening publication-title: Soc Sci Med doi: 10.1016/0277-9536(90)90294-3 – volume: 3 start-page: 47 issue: 1 year: 1996 end-page: 53 ident: CR158 article-title: Screening for melanoma by primary health care physicians: a cost-effectiveness analysis publication-title: J Med Screen – volume: 3 start-page: 125 issue: 2 year: 1992 end-page: 36 ident: CR94 article-title: Optimization of cervical cancer screening publication-title: Cancer Causes Control doi: 10.1007/BF00051652 – volume: 7 start-page: 308 issue: 4 year: 1965 end-page: 13 ident: CR16 article-title: A simplex method for function minimization publication-title: Comput J doi: 10.1093/comjnl/7.4.308 – volume: 107 start-page: 321 issue: 2 year: 2006 end-page: 8 ident: CR104 article-title: Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests publication-title: Obstet Gynecol doi: 10.1097/01.AOG.0000196500.50044.ce – volume: 7 start-page: 9 issue: 1 year: 1998 end-page: 20 ident: CR124 article-title: Colorectal cancer screening: efficiency and effectiveness publication-title: Health Econ doi: 10.1002/(SICI)1099-1050(199802)7:1<9::AID-HEC304>3.0.CO;2-H – volume: 43 start-page: 127 issue: 1 year: 1987 end-page: 44 ident: CR149 article-title: The natural history of lung cancer in a periodically screened population publication-title: Biometrics doi: 10.2307/2531955 – volume: 8 start-page: 39 issue: 1 year: 2001 end-page: 45 ident: CR46 article-title: Computer modelling of the Swedish two county trial of mammographic screening and trade offs between participation and screening interval publication-title: J Med Screen doi: 10.1136/jms.8.1.39 – volume: 22 start-page: 2554 issue: 13 year: 2004 end-page: 66 ident: CR60 article-title: Benefits and costs of interventions to improve breast cancer outcomes in African American women publication-title: J Clin Oncol doi: 10.1200/JCO.2004.05.009 – volume: 95 start-page: 868 issue: 12 year: 2003 end-page: 78 ident: CR164 article-title: Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer publication-title: J Natl Cancer Inst doi: 10.1093/jnci/95.12.868 – volume: 42 start-page: 246 issue: 1 year: 1998 end-page: 52 ident: CR111 article-title: Interactive neural-network-assisted screening: an economic assessment publication-title: Acta Cytol doi: 10.1159/000331553 – volume: 36 start-page: 37 year: 2006 end-page: 47 ident: CR48 article-title: The Wisconsin breast cancer epidemiology simulation model publication-title: J Natl Cancer Inst Monogr doi: 10.1093/jncimonographs/lgj007 – volume: 5 start-page: 11 issue: 1 year: 2003 end-page: 9 ident: CR64 article-title: Estimates of breast cancer growth rate and sojourn time from screening database information publication-title: J Wom Imag doi: 10.1097/00130747-200302000-00003 – volume: 26 start-page: 581 issue: 3 year: 2006 end-page: 95 ident: CR72 article-title: A natural history model of stage progression applied to breast cancer publication-title: Stat Med doi: 10.1002/sim.2550 – year: 2000 ident: CR12 publication-title: Simulation modeling and analysis – volume: 5 start-page: 3 issue: 1 year: 2003 end-page: 10 ident: CR65 article-title: Estimates of the sizes at which breast cancers become detectable on mammographic and clinical grounds publication-title: J Wom Imag doi: 10.1097/00130747-200302000-00002 – volume: 4 start-page: 257 issue: 4 year: 2001 end-page: 67 ident: CR121 article-title: Analysis of colorectal cancer screening regimens publication-title: Health Care Manage Sci doi: 10.1023/A:1011886010184 – volume: 115 start-page: 268 issue: 2 year: 2005 end-page: 75 ident: CR83 article-title: Natural history and screening model for high-risk human papillomavirus infection, neoplasia and cervical cancer in the Netherlands publication-title: Int J Cancer doi: 10.1002/ijc.20846 – volume: 1 start-page: 190 issue: 3 year: 1989 end-page: 206 ident: CR24 article-title: Tabu search: part I publication-title: ORSA J Computing doi: 10.1287/ijoc.1.3.190 – volume: 5 start-page: 249 issue: 4 year: 2002 end-page: 58 ident: CR144 article-title: A simulation to evaluate screening for Helicobacter pylori infection in the prevention of peptic ulcers and gastric cancers publication-title: Health Care Manage Sci doi: 10.1023/A:1020326005465 – volume: 5 start-page: 81 issue: 2 year: 1998 end-page: 7 ident: CR29 article-title: Radiation risk of mammography related to benefit in screening programmes: a favourable balance? publication-title: J Med Screen – volume: 145 start-page: 1 year: 2006 end-page: 100 ident: CR160 article-title: Genomic tests for ovarian cancer detection and management publication-title: Evid Rep Technol Assess (Full Rep) – volume: 76 start-page: 309 issue: 905 year: 2003 end-page: 20 ident: CR28 article-title: Analysis of benefit: risk ratio and mortality reduction for the UK Breast Screening Programme publication-title: Br J Radiol doi: 10.1259/bjr/64009424 – volume: 30 start-page: 1067 issue: 12 year: 1992 end-page: 82 ident: CR98 article-title: Effect of the Clinical Laboratory Improvement Amendments of 1988 (CLIA ‘88) on the incidence of invasive cervical cancer publication-title: Med Care doi: 10.1097/00005650-199212000-00001 – volume: 28 start-page: 453 issue: 6 year: 2004 end-page: 60 ident: CR51 article-title: Simulation modeling of change to breast cancer detection age eligibility recommendations in Ontario, 2002-2021 publication-title: Cancer Detect Prev doi: 10.1016/j.cdp.2004.08.003 – volume: 135 start-page: 769 issue: 9 year: 2001 end-page: 81 ident: CR127 article-title: Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer: a cost-effectiveness analysis publication-title: Ann Intern Med – volume: 20 start-page: 434 issue: 4 year: 2004 end-page: 9 ident: CR130 article-title: Cost-effectiveness analysis of fecal occult blood screening for colorectal cancer publication-title: Int J Technol Assess Health Care doi: 10.1017/S0266462304001321 – volume: 353 start-page: 2158 issue: 20 year: 2005 end-page: 68 ident: CR91 article-title: Cost-effectiveness of cervical-cancer screening in five developing countries publication-title: N Engl J Med doi: 10.1056/NEJMsa044278 – volume: 92 start-page: 557 issue: 7 year: 2000 end-page: 63 ident: CR132 article-title: Endoscopic colorectal cancer screening: a cost-saving analysis publication-title: J Natl Cancer Inst doi: 10.1093/jnci/92.7.557 – volume: 47 start-page: 987 issue: 3 year: 1991 end-page: 1004 ident: CR175 article-title: Nonparametric estimation of the size-metastasis relationship in solid cancers publication-title: Biometrics doi: 10.2307/2532654 – volume: 118 start-page: 2020 issue: 8 year: 2006 end-page: 5 ident: CR47 article-title: Seventy-five years is an appropriate upper age limit for population-based mammography screening publication-title: Int J Cancer doi: 10.1002/ijc.21560 – volume: 126 start-page: 1270 issue: 5 year: 2004 end-page: 9 ident: CR136 article-title: Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis publication-title: Gastroenterology doi: 10.1053/j.gastro.2004.02.016 – volume: 47 start-page: 3 issue: 1 year: 1994 end-page: 21 ident: CR163 article-title: A Markov model of the natural history of prostate cancer publication-title: J Clin Epidemiol doi: 10.1016/0895-4356(94)90029-9 – volume: 13 start-page: 8 issue: 1 year: 2006 end-page: 13 ident: CR142 article-title: Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan publication-title: J Med Screen doi: 10.1258/096914106776179782 – volume: 166 start-page: 137 issue: 2 year: 2007 end-page: 50 ident: CR178 article-title: Multiparameter calibration of a natural history model of cervical cancer publication-title: Am J Epidemiol 2007 July 15 doi: 10.1093/aje/kwm086 – volume: 6 start-page: 132 issue: 3 year: 1999 end-page: 8 ident: CR34 article-title: Stage distribution at first and repeat examinations in breast cancer screening publication-title: J Med Screen – volume: 91 start-page: 242 issue: 2 year: 2004 end-page: 7 ident: CR82 article-title: Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality publication-title: Br J Cancer – volume: 18 start-page: 251 issue: 3 year: 1997 end-page: 70 ident: CR10 article-title: Use of a stochastic simulation model to identify an efficient protocol for ovarian cancer screening publication-title: Control Clin Trials doi: 10.1016/S0197-2456(96)00233-4 – volume: 66 start-page: 1601 issue: 7 year: 1990 end-page: 12 ident: CR81 article-title: A model for breast cancer screening publication-title: Cancer doi: 10.1002/1097-0142(19901001)66:7<1601::AID-CNCR2820660727>3.0.CO;2-O – volume: 171 start-page: 155 issue: 2 year: 2001 end-page: 78 ident: CR69 article-title: A mathematical algorithm that computes breast cancer sizes and doubling times detected by screening publication-title: Math Biosci doi: 10.1016/S0025-5564(01)00054-2 – volume: 21 start-page: 531 issue: 49 year: 1991 end-page: 7 ident: CR42 article-title: Breast cancer screening and cost-effectiveness: policy alternatives, quality of life considerations and the possible impact of uncertain factors publication-title: Int J Cancer doi: 10.1002/ijc.2910490410 – volume: 51 start-page: 551 issue: 4 year: 1985 end-page: 68 ident: CR109 article-title: A computer simulation model for the practical planning of cervical cancer screening programmes publication-title: Br J Cancer doi: 10.1038/bjc.1985.78 – volume: 33 start-page: 345 year: 2003 end-page: 60 ident: CR36 article-title: A computer model for the study of breast cancer publication-title: Comput Biol Med doi: 10.1016/S0010-4825(03)00003-9 – volume: 159 start-page: 142 issue: 2 year: 1999 end-page: 8 ident: CR145 article-title: Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer publication-title: Arch Intern Med doi: 10.1001/archinte.159.2.142 – volume: 4 start-page: 3 year: 1984 end-page: 10 ident: CR45 article-title: Inferring the natural time history of breast cancer: implications for tumor growth rate and early detection publication-title: Breast Cancer Res Treat doi: 10.1007/BF01806982 – volume: 12 start-page: 77 issue: 1 year: 2003 end-page: 84 ident: CR129 article-title: A simulation model for evaluating the medical and economic outcomes of screening strategies for colorectal cancer publication-title: Eur J Cancer Prev doi: 10.1097/00008469-200302000-00012 – volume: 130 start-page: 97 issue: 2 year: 1999 end-page: 107 ident: CR87 article-title: The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women publication-title: Ann Intern Med – volume: 7 start-page: 11 issue: 1 year: 1985 end-page: 20 ident: CR96 article-title: Model building on the basis of Dutch cervical cancer screening data publication-title: Maturitas doi: 10.1016/0378-5122(85)90030-1 – volume: 22 start-page: 1661 issue: 10 year: 2003 end-page: 74 ident: CR66 article-title: Bayesian evaluation of breast cancer screening using data from two studies publication-title: Stat Med doi: 10.1002/sim.1365 – volume: 46 start-page: 207 issue: 2 year: 1990 end-page: 13 ident: CR80 article-title: A model-based analysis of the HIP project for breast cancer screening publication-title: Int J Cancer doi: 10.1002/ijc.2910460211 – volume: 6 start-page: 604 issue: 4 year: 2005 end-page: 14 ident: CR74 article-title: Robust modeling in screening studies: estimation of sensitivity and preclinical sojourn time distribution publication-title: Biostatistics doi: 10.1093/biostatistics/kxi030 – volume: 36 start-page: 30 year: 2006 end-page: 6 ident: CR31 article-title: Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach publication-title: J Natl Cancer Inst Monogr doi: 10.1093/jncimonographs/lgj006 – volume: 32 start-page: 13 issue: 1 year: 1999 end-page: 33 ident: CR131 article-title: The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening publication-title: Comput Biomed Res doi: 10.1006/cbmr.1998.1498 – year: 1998 ident: CR14 publication-title: Handbook of simulation: principles, methodology, advances, applications, and practice – volume: 61 start-page: 992 issue: 4 year: 2005 end-page: 9 ident: CR73 article-title: Nonparametric estimation of asymptomatic duration from a randomized prospective cancer screening trial publication-title: Biometrics doi: 10.1111/j.1541-0420.2005.00363.x – volume: 6 start-page: 9 issue: 1 year: 2003 end-page: 17 ident: CR180 article-title: Principles of good practice for decision analytic modeling in health-care evaluation. Report of the ISPOR task force on good research practices: modeling studies publication-title: Value Health doi: 10.1046/j.1524-4733.2003.00234.x – volume: 36 start-page: 47 year: 2006 end-page: 55 ident: CR61 article-title: The SPECTRUM population model of the impact of screening and treatment on U.S. breast cancer trends from 1975 to 2000: principles and practice of the model methods publication-title: J Natl Cancer Inst Monogr doi: 10.1093/jncimonographs/lgj008 – year: 1990 ident: CR108 publication-title: The costs and effectiveness of screening for cervical cancer in elderly women: background paper, OTA-BP-H-65 – volume: 287 start-page: 2372 issue: 18 year: 2002 end-page: 81 ident: CR9 article-title: Benefits and costs of using HPV testing to screen for cervical cancer publication-title: JAMA doi: 10.1001/jama.287.18.2372 – volume: 36 start-page: 66 year: 2006 end-page: 78 ident: CR49 article-title: The University of Rochester model of breast cancer detection and survival publication-title: J Natl Cancer Inst Monogr doi: 10.1093/jncimonographs/lgj010 – volume: 13 start-page: 54 issue: 1 year: 2006 end-page: 8 ident: CR176 article-title: Evolution of multiple disease screening in Keelung: a model for community involvement in health interventions? publication-title: J Med Screen doi: 10.1258/096914106776179809 – volume: 60 start-page: 1117 issue: 5 year: 1987 end-page: 22 ident: CR85 article-title: The frequency of cervical cancer screening: comparison of a mathematical model with empirical data publication-title: Cancer doi: 10.1002/1097-0142(19870901)60:5<1117::AID-CNCR2820600533>3.0.CO;2-H – volume: 287 start-page: 2382 issue: 18 year: 2002 end-page: 90 ident: CR99 article-title: Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance publication-title: JAMA doi: 10.1001/jama.287.18.2382 – volume: 80 start-page: 337 issue: 5 year: 1988 end-page: 44 ident: CR150 article-title: Natural history of adenocarcinoma-large cell carcinoma of the lung: conclusions from screening programs in New York and Baltimore publication-title: J Natl Cancer Inst doi: 10.1093/jnci/80.5.337 – volume: 31 start-page: 348 issue: 3 year: 1995 end-page: 53 ident: CR68 article-title: A model-based prediction of the impact on reduction in mortality by a breast cancer screening programme in the city of Florence, Italy publication-title: Eur J Cancer doi: 10.1016/0959-8049(95)94001-F – volume: 14 start-page: 925 issue: 4 year: 2000 end-page: 38 ident: CR1 article-title: Simulation modeling of outcomes and cost-effectiveness publication-title: Hematol Oncol Clin North Am doi: 10.1016/S0889-8588(05)70319-1 – volume: 36 start-page: 79 year: 2006 end-page: 86 ident: CR59 article-title: A stochastic model for predicting the mortality of breast cancer publication-title: J Natl Cancer Inst Monogr doi: 10.1093/jncimonographs/lgj011 – volume: 60 start-page: 132 issue: 1 year: 1989 end-page: 41 ident: CR92 article-title: Natural history of cervical neoplasia: consistent results obtained by an identification technique publication-title: Br J Cancer doi: 10.1038/bjc.1989.236 – volume: 17 start-page: 785 issue: 5 year: 2006 end-page: 93 ident: CR148 article-title: Computed tomography screening for lung cancer in Hodgkin’s lymphoma survivors: decision analysis and cost-effectiveness analysis publication-title: Ann Oncol doi: 10.1093/annonc/mdl023 – volume: 10 start-page: 1 issue: 8 year: 2006 end-page: 142 ident: CR143 article-title: Surveillance of Barrett’s oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling publication-title: Health Technol Assess – volume: 17 start-page: 42 issue: 1 year: 1993 end-page: 50 ident: CR35 article-title: Cost-effectiveness of mammographic screening in Australia publication-title: Aust J Public Health doi: 10.1111/j.1753-6405.1993.tb00103.x – year: 1996 ident: CR22 publication-title: Genetic algorithms vs. simulated annealing: a comparison of approaches for solving the circuit partitioning problem – volume: 118 start-page: 1759 issue: 7 year: 2006 end-page: 68 ident: CR84 article-title: Evaluation of cervical screening strategies with adjunct high-risk human papillomavirus testing for women with borderline or mild dyskaryosis publication-title: Int J Cancer doi: 10.1002/ijc.21513 – volume: 220 start-page: 671 issue: 4598 year: 1983 end-page: 80 ident: CR17 article-title: Optimization by simulated annealing publication-title: Science doi: 10.1126/science.220.4598.671 – volume: 21 start-page: 3369 issue: 22 year: 2002 end-page: 82 ident: CR50 article-title: Assessing chronic disease progression using non-homogeneous exponential regression Markov models: an illustration using a selective breast cancer screening in Taiwan publication-title: Stat Med doi: 10.1002/sim.1277 – volume: 24 start-page: 3123 issue: 20 year: 2005 end-page: 38 ident: CR40 article-title: Estimation of age-specific sensitivity and sojourn time in breast cancer screening studies publication-title: Stat Med doi: 10.1002/sim.2178 – volume: 14 start-page: 227 issue: 4 year: 1997 end-page: 32 ident: CR159 article-title: An interim determination of health gain from oral cancer and precancer screening: 2. Developing a model of population screening publication-title: Community Dent Health – volume: 40 start-page: 83 issue: 7 year: 2003 ident: CR52 article-title: Prevalence of family histories of breast cancer in the general population and the incidence of related seeking of health care [letter] publication-title: J Med Genet doi: 10.1136/jmg.40.7.e83 – volume: 87 start-page: 1217 issue: 16 year: 1995 end-page: 23 ident: CR43 article-title: Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials publication-title: J Natl Cancer Inst doi: 10.1093/jnci/87.16.1217 – volume: 98 start-page: 774 issue: 11 year: 2006 end-page: 82 ident: CR75 article-title: Retrospective cost-effectiveness analysis of screening mammography publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djj210 – volume: 25 start-page: 2846 issue: 16 year: 2006 end-page: 66 ident: CR174 article-title: A population model of prostate cancer incidence publication-title: Stat Med doi: 10.1002/sim.2257 – year: 1997 ident: CR15 publication-title: Computational handbook of statistics – volume: 16 start-page: 799 issue: 3 year: 2000 end-page: 810 ident: CR126 article-title: A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults publication-title: Int J Technol Assess Health Care doi: 10.1017/S0266462300102077 – volume: 2 start-page: 147 issue: 3 year: 1991 end-page: 55 ident: CR155 article-title: Evaluation of cancer prevention strategies by computerized simulation model: an approach to lung cancer publication-title: Cancer Causes Control doi: 10.1007/BF00056207 – volume: 113 start-page: 214 issue: 3 year: 1990 end-page: 26 ident: CR86 article-title: Screening for cervical cancer publication-title: Ann Intern Med – volume: 13 start-page: 421 year: 2004 end-page: 42 ident: CR3 article-title: The use of modeling to understand the impact of screening on US mortality: examples from mammography and PSA testing publication-title: Stat Methods Med Res doi: 10.1191/0962280204sm376ra – volume: 31 start-page: 102 year: 2003 end-page: 10 ident: CR4 article-title: Chapter 15: public health policy and cost-effectiveness analysis publication-title: J Natl Cancer Inst Monogr doi: 10.1093/oxfordjournals.jncimonographs.a003471 – volume: 212 start-page: 551 issue: 2 year: 1999 end-page: 60 ident: CR63 article-title: Breast cancer: computer simulation method for estimating optimal intervals for screening publication-title: Radiology – volume: 7 start-page: 1 issue: 6 year: 2003 end-page: 86 ident: CR146 article-title: The cost-effectiveness of screening for Helicobacter pylori to reduce mortality and morbidity from gastric cancer and peptic ulcer disease: a discrete-event simulation model publication-title: Health Technol Assess – volume: 40 start-page: 143 issue: 2 year: 1986 end-page: 53 ident: CR110 article-title: An evaluation of screening policies for cervical cancer in England and Wales using a computer simulation model publication-title: J Epidemiol Community Health doi: 10.1136/jech.40.2.143 – volume: 318 start-page: 356 issue: 7180 year: 1999 end-page: 60 ident: CR115 article-title: Withdrawing low risk women from cervical screening programmes: mathematical modelling study publication-title: BMJ doi: 10.1136/bmj.318.7180.356 – volume: 24 start-page: 1043 issue: 11 year: 2006 end-page: 53 ident: CR6 article-title: Recent developments in decision-analytic modelling for economic evaluation publication-title: Pharmacoeconomics doi: 10.2165/00019053-200624110-00002 – volume: 36 start-page: 56 year: 2006 end-page: 65 ident: CR77 article-title: The MISCAN-Fadia continuous tumor growth model for breast cancer publication-title: J Natl Cancer Inst Monogr doi: 10.1093/jncimonographs/lgj009 – volume: 5 start-page: 11 issue: 1 year: 2007 ident: CR179 article-title: Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination publication-title: Popul Health Metr doi: 10.1186/1478-7954-5-11 – start-page: 321 year: 1996 end-page: 56 ident: CR139 article-title: Cost-effectiveness of colorectal cancer screening in average-risk adults publication-title: Prevention and early detection of colorectal cancer – year: 1975 ident: CR20 publication-title: Adaptation in natural and artificial systems – volume: 12 start-page: 355 issue: 3-4 year: 1995 end-page: 67 ident: CR134 article-title: Cost-effectiveness of screening for colorectal cancer: a simulation model publication-title: IMA J Math Appl Med Biol doi: 10.1093/imammb/12.3-4.355 – volume: 83 start-page: 251 issue: 3 year: 1992 end-page: 7 ident: CR156 article-title: A 50-year projection of lung cancer deaths among Japanese males and potential impact evaluation of anti-smoking measures and screening using a computerized simulation model publication-title: Jpn J Cancer Res doi: 10.1111/j.1349-7006.1992.tb00096.x – volume: 284 start-page: 1954 issue: 15 year: 2000 end-page: 61 ident: CR122 article-title: Cost-effectiveness of screening for colorectal cancer in the general population publication-title: JAMA doi: 10.1001/jama.284.15.1954 – volume: 111 start-page: 593 issue: 8 year: 2001 end-page: 601 ident: CR137 article-title: Which colon cancer screening test? A comparison of costs, effectiveness, and compliance publication-title: Am J Med doi: 10.1016/S0002-9343(01)00977-9 – volume: 26 start-page: 130 issue: 2 year: 2004 end-page: 7 ident: CR100 article-title: Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong publication-title: J Public Health (Oxf) doi: 10.1093/pubmed/fdh138 – volume: 94 start-page: 981 issue: 13 year: 2002 end-page: 90 ident: CR169 article-title: Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends publication-title: J Natl Cancer Inst doi: 10.1093/jnci/94.13.981 – volume: 96 start-page: 429 issue: 454 year: 2001 end-page: 39 ident: CR162 article-title: Screening based on the risk of cancer calculation from Bayesian hierarchical change point and mixture models of longitudinal markers publication-title: J Am Stat Assoc doi: 10.1198/016214501753168145 – volume: 91 start-page: 84 issue: 1 year: 2004 end-page: 91 ident: CR116 article-title: An evaluation of liquid-based cytology and human papillomavirus testing within the UK Cervical Cancer Screening Programme publication-title: Br J Cancer doi: 10.1038/sj.bjc.6601884 – volume: 44 start-page: 365 issue: 4-5 year: 1991 end-page: 80 ident: CR161 article-title: Quantifying the potential benefit of CA 125 screening for ovarian cancer publication-title: J Clin Epidemiol doi: 10.1016/0895-4356(91)90075-K – volume: 10 start-page: 148 issue: 3 year: 2003 end-page: 56 ident: CR147 article-title: Cost-effectiveness of population screening for Helicobacter pylori in preventing gastric cancer and peptic ulcer disease, using simulation publication-title: J Med Screen doi: 10.1258/096914103769011067 – start-page: 17 year: 1973 end-page: 55 ident: CR101 article-title: A simulation system for screening procedures publication-title: Future and present indicatives, problems and progress in medical care – volume: 36 start-page: 1 issue: 1 year: 1982 end-page: 10 ident: CR117 article-title: Optimising the age, number of tests, and test interval for cervical screening in Canada publication-title: J Epidemiol Community Health doi: 10.1136/jech.36.1.1 – volume: 115 start-page: 807 issue: 10 year: 1991 end-page: 17 ident: CR138 article-title: Cost effectiveness of colorectal cancer screening in the elderly publication-title: Ann Intern Med – volume: 25 start-page: 203 year: 2007 end-page: 8 ident: CR2 article-title: Use of modeling to evaluate the cost-effectiveness of cancer screening programs publication-title: J Clin Oncol doi: 10.1200/JCO.2006.07.9202 – volume: 103 start-page: 619 issue: 4 year: 2004 end-page: 31 ident: CR89 article-title: Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more publication-title: Obstet Gynecol doi: 10.1097/01.AOG.0000120143.50098.c7 – volume: 6 start-page: 9 issue: 1 year: 2003 Jan-Feb ident: R180-2-20090810 publication-title: Value Health doi: 10.1046/j.1524-4733.2003.00234.x – year: 2002 ident: R18-2 – volume: 60 start-page: 1117 issue: 5 year: 1987 Sep 1 ident: R85-2-20090810 publication-title: Cancer doi: 10.1002/1097-0142(19870901)60:5<1117::AID-CNCR2820600533>3.0.CO;2-H – volume: 95 start-page: 1800 issue: 7 year: 2000 Jul ident: R135-2-20090810 publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2000.02172.x – volume: 119 start-page: 2366 issue: 10 year: 2006 Nov 15 ident: R166-2-20090810 publication-title: Int J Cancer doi: 10.1002/ijc.22158 – volume: 166 start-page: 137 issue: 2 year: 2007 July 15, 2007 ident: R178-2-20090810 publication-title: Am J Epidemiol doi: 10.1093/aje/kwm086 – volume: 2 start-page: 147 issue: 3 year: 1991 May ident: R155-2-20090810 publication-title: Cancer Causes Control doi: 10.1007/BF00056207 – volume: 7 start-page: 135 issue: 3 year: 1997 Sep ident: R107-2-20090810 publication-title: J Epidemiol doi: 10.2188/jea.7.135 – volume: 26 start-page: 130 issue: 2 year: 2004 Jun ident: R100-2-20090810 publication-title: J Public Health (Oxf) doi: 10.1093/pubmed/fdh138 – volume: 94 start-page: 981 issue: 13 year: 2002 Jul 3 ident: R169-2-20090810 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/94.13.981 – volume: 43 start-page: 127 issue: 1 year: 1987 Mar ident: R149-2-20090810 publication-title: Biometrics doi: 10.2307/2531955 – start-page: 321 year: 1996 ident: R139-2 – volume: 60 start-page: 132 issue: 1 year: 1989 Jul ident: R92-2-20090810 publication-title: Br J Cancer doi: 10.1038/bjc.1989.236 – volume: 106 start-page: 896 year: 2003 ident: R7-2-20090810 publication-title: Int J Cancer doi: 10.1002/ijc.11334 – volume: 284 start-page: 1954 issue: 15 year: 2000 Oct 18 ident: R122-2-20090810 publication-title: JAMA doi: 10.1001/jama.284.15.1954 – volume: 5 start-page: 81 issue: 2 year: 1998 ident: R29-2-20090810 publication-title: J Med Screen doi: 10.1136/jms.5.2.81 – volume: 51 start-page: 551 issue: 4 year: 1985 Apr ident: R109-2-20090810 publication-title: Br J Cancer doi: 10.1038/bjc.1985.78 – volume: 70 start-page: 619 issue: 834 year: 1997 Jun ident: R55-2-20090810 publication-title: Br J Radiol doi: 10.1259/bjr.70.834.9227256 – volume: 22 start-page: 1661 issue: 10 year: 2003 May 30 ident: R66-2-20090810 publication-title: Stat Med doi: 10.1002/sim.1365 – volume: 295 start-page: 2374 issue: 20 year: 2006 May 24 ident: R70-2-20090810 publication-title: JAMA doi: 10.1001/jama.295.20.2374 – year: 1996 ident: R22-2 – volume: 29 start-page: 159 issue: 2 year: 1987 May ident: R97-2-20090810 publication-title: Eur J Oper Res doi: 10.1016/0377-2217(87)90105-6 – volume: 10 start-page: 1 issue: 8 year: 2006 Mar ident: R143-2-20090810 publication-title: Health Technol Assess doi: 10.3310/hta10080 – volume: 287 start-page: 2372 issue: 18 year: 2002 May 8 ident: R9-2-20090810 publication-title: JAMA doi: 10.1001/jama.287.18.2372 – volume: 10 start-page: 160 issue: 3 year: 2004 May-Jun ident: R141-2-20090810 publication-title: Cancer J doi: 10.1097/00130404-200405000-00005 – volume: 44 start-page: 365 issue: 4-5 year: 1991 ident: R161-2-20090810 publication-title: J Clin Epidemiol doi: 10.1016/0895-4356(91)90075-K – volume: 96 start-page: 429 issue: 454 year: 2001 ident: R162-2-20090810 publication-title: J Am Stat Assoc doi: 10.1198/016214501753168145 – volume: 26 start-page: 581 issue: 3 year: 2006 ident: R72-2-20090810 publication-title: Stat Med doi: 10.1002/sim.2550 – volume: 43 start-page: 1006 issue: 6 year: 1999 Nov-Dec ident: R112-2-20090810 publication-title: Acta Cytol doi: 10.1159/000331346 – volume: 2 start-page: 4 issue: 1 year: 1990 ident: R25-2-20090810 publication-title: ORSA J Computing doi: 10.1287/ijoc.2.1.4 – volume: 47 Spec No start-page: 32 year: 1992 Nov ident: R62-2-20090810 publication-title: J Gerontol – volume: 289 start-page: 313 issue: 3 year: 2003 Jan 15 ident: R153-2-20090810 publication-title: JAMA doi: 10.1001/jama.289.3.313 – year: 1998 ident: R14-2 – volume: 102 start-page: 67 year: 1994 Nov ident: R157-2-20090810 publication-title: Environ Health Perspect doi: 10.1289/ehp.94102s867 – volume: 36 start-page: 37 year: 2006 ident: R48-2-20090810 publication-title: J Natl Cancer Inst Monogr doi: 10.1093/jncimonographs/lgj007 – start-page: 17 year: 1973 ident: R101-2 – volume: 92 start-page: 106 year: 2003 Dec ident: R165-2-20090810 publication-title: BJU Int doi: 10.1111/j.1464-410X.2003.4409x.x – volume: 26 start-page: 31 issue: 6 year: 2004 Nov-Dec ident: R37-2-20090810 publication-title: J Healthc Qual doi: 10.1111/j.1945-1474.2004.tb00534.x – year: 1988 ident: R19-2 – volume: 49 start-page: 531 year: 1991 Oct 21 ident: R42-2-20090810 publication-title: Int J Cancer doi: 10.1002/ijc.2910490410 – volume: 36 start-page: 86 year: 2006 ident: R71-2-20090810 publication-title: J Natl Cancer Inst Monogr doi: 10.1093/jncimonographs/lgj012 – volume: 42 start-page: 246 issue: 1 year: 1998 Jan-Feb ident: R111-2-20090810 publication-title: Acta Cytol doi: 10.1159/000331553 – volume: 52 start-page: 515 issue: 4 year: 1985 Oct ident: R58-2-20090810 publication-title: Br J Cancer doi: 10.1038/bjc.1985.222 – volume: 126 start-page: 1270 issue: 5 year: 2004 May ident: R136-2-20090810 publication-title: Gastroenterology doi: 10.1053/j.gastro.2004.02.016 – volume: 43 start-page: 1055 issue: 6 year: 1989 Jun 15 ident: R79-2-20090810 publication-title: Int J Cancer doi: 10.1002/ijc.2910430617 – volume: 24 start-page: 1043 issue: 11 year: 2006 ident: R6-2-20090810 publication-title: Pharmacoeconomics doi: 10.2165/00019053-200624110-00002 – volume: 91 start-page: 242 issue: 2 year: 2004 Jul 19 ident: R82-2-20090810 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6601969 – volume: 40 start-page: 143 issue: 2 year: 1986 Jun ident: R110-2-20090810 publication-title: J Epidemiol Community Health doi: 10.1136/jech.40.2.143 – volume: 83 start-page: 251 issue: 3 year: 1992 Mar ident: R156-2-20090810 publication-title: Jpn J Cancer Res doi: 10.1111/j.1349-7006.1992.tb00096.x – volume: 25 start-page: 2846 issue: 16 year: 2006 Aug 30 ident: R174-2-20090810 publication-title: Stat Med doi: 10.1002/sim.2257 – volume: 24 start-page: 137 issue: 2 year: 1997 Feb ident: R56-2-20090810 publication-title: Eur J Radiol doi: 10.1016/S0720-048X(96)01054-6 – volume: 67 start-page: 2021 issue: 8 year: 1991 Apr 15 ident: R67-2-20090810 publication-title: Cancer doi: 10.1002/1097-0142(19910415)67:8<2021::AID-CNCR2820670802>3.0.CO;2-L – volume: 349 start-page: 1501 issue: 16 year: 2003 Oct 16 ident: R113-2-20090810 publication-title: N Engl J Med doi: 10.1056/NEJMoa035419 – volume: 94 start-page: 1361 issue: 10 year: 2006 May 22 ident: R171-2-20090810 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6603105 – volume: 25 start-page: 203 year: 2007 ident: R2-2-20090810 publication-title: J Clin Oncol doi: 10.1200/JCO.2006.07.9202 – volume: 118 start-page: 1759 issue: 7 year: 2006 Apr 1 ident: R84-2-20090810 publication-title: Int J Cancer doi: 10.1002/ijc.21513 – volume: 13 start-page: 507 issue: 6 year: 2004 Dec ident: R39-2-20090810 publication-title: Stat Methods Med Res doi: 10.1191/0962280204sm380ra – volume: 98 start-page: 774 issue: 11 year: 2006 Jun 7 ident: R75-2-20090810 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djj210 – volume: 17 start-page: 42 issue: 1 year: 1993 Mar ident: R35-2-20090810 publication-title: Aust J Public Health doi: 10.1111/j.1753-6405.1993.tb00103.x – volume: 38 start-page: 101 issue: 2 year: 1996 Nov ident: R76-2-20090810 publication-title: Health Policy doi: 10.1016/0168-8510(96)00843-3 – volume: 36 start-page: 30 year: 2006 ident: R31-2-20090810 publication-title: J Natl Cancer Inst Monogr doi: 10.1093/jncimonographs/lgj006 – volume: 7 start-page: 1 issue: 6 year: 2003 ident: R146-2-20090810 publication-title: Health Technol Assess doi: 10.3310/hta7060 – volume: 18 start-page: 251 issue: 3 year: 1997 Jun ident: R10-2-20090810 publication-title: Control Clin Trials doi: 10.1016/S0197-2456(96)00233-4 – volume: 36 start-page: 79 year: 2006 ident: R59-2-20090810 publication-title: J Natl Cancer Inst Monogr doi: 10.1093/jncimonographs/lgj011 – volume: 24 start-page: 155 issue: S3 year: 2006 Aug 31 ident: R5-2-20090810 publication-title: Vaccine doi: 10.1016/j.vaccine.2006.05.112 – volume: 7 start-page: 308 issue: 4 year: 1965 ident: R16-2-20090810 publication-title: Comput J doi: 10.1093/comjnl/7.4.308 – volume: 8 start-page: 39 issue: 1 year: 2001 ident: R46-2-20090810 publication-title: J Med Screen doi: 10.1136/jms.8.1.39 – volume: 3 start-page: 47 issue: 1 year: 1996 ident: R158-2-20090810 publication-title: J Med Screen doi: 10.1177/096914139600300112 – volume: 5 start-page: 11 issue: 1 year: 2003 Feb ident: R64-2-20090810 publication-title: J Wom Imag doi: 10.1097/00130747-200302000-00003 – volume: 36 start-page: 623 issue: 5 year: 1989 ident: R118-2-20090810 publication-title: Neoplasma – volume: 21 start-page: 3369 issue: 22 year: 2002 Nov 30 ident: R50-2-20090810 publication-title: Stat Med doi: 10.1002/sim.1277 – volume: 113 start-page: 214 issue: 3 year: 1990 Aug 1 ident: R86-2-20090810 publication-title: Ann Intern Med doi: 10.7326/0003-4819-113-3-214 – volume: 80 start-page: 337 issue: 5 year: 1988 May 4 ident: R150-2-20090810 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/80.5.337 – volume: 111 start-page: 593 issue: 8 year: 2001 Dec 1 ident: R137-2-20090810 publication-title: Am J Med doi: 10.1016/S0002-9343(01)00977-9 – volume: 3 start-page: 125 issue: 2 year: 1992 Mar ident: R94-2-20090810 publication-title: Cancer Causes Control doi: 10.1007/BF00051652 – volume: 26 start-page: 1172 issue: 6 year: 1997 Dec ident: R123-2-20090810 publication-title: Int J Epidemiol doi: 10.1093/ije/26.6.1172 – volume: 12 start-page: 77 issue: 1 year: 2003 Feb ident: R129-2-20090810 publication-title: Eur J Cancer Prev doi: 10.1097/00008469-200302000-00012 – volume: 220 start-page: 671 issue: 4598 year: 1983 ident: R17-2-20090810 publication-title: Science doi: 10.1126/science.220.4598.671 – volume: 111 start-page: 389 issue: 5 year: 1989 ident: R44-2-20090810 publication-title: Ann Intern Med doi: 10.7326/0003-4819-111-5-389 – volume: 317 start-page: 376 issue: 7155 year: 1998 Aug 8 ident: R33-2-20090810 publication-title: BMJ doi: 10.1136/bmj.317.7155.376 – volume: 14 start-page: 925 issue: 4 year: 2000 Aug ident: R1-2-20090810 publication-title: Hematol Oncol Clin North Am doi: 10.1016/S0889-8588(05)70319-1 – volume: 12 start-page: 355 issue: 3-4 year: 1995 Sep-Dec ident: R134-2-20090810 publication-title: IMA J Math Appl Med Biol doi: 10.1093/imammb/12.3-4.355 – volume: 151 start-page: 991 issue: 10 year: 2000 May 15 ident: R41-2-20090810 publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a010143 – volume: 212 start-page: 551 issue: 2 year: 1999 Aug ident: R63-2-20090810 publication-title: Radiology doi: 10.1148/radiology.212.2.r99au49551 – volume: 101 start-page: 495 issue: 3 year: 2004 Aug 1 ident: R32-2-20090810 publication-title: Cancer doi: 10.1002/cncr.20392 – volume: 22 start-page: 2554 issue: 13 year: 2004 Jul 1 ident: R60-2-20090810 publication-title: J Clin Oncol doi: 10.1200/JCO.2004.05.009 – volume: 272 start-page: 773 issue: 10 year: 1994 Sep 14 ident: R170-2-20090810 publication-title: JAMA doi: 10.1001/jama.1994.03520100035030 – volume: 16 start-page: 87 issue: 11 year: 1992 ident: R23-2-20090810 publication-title: Math Comput Model doi: 10.1016/0895-7177(92)90108-W – volume: 46 start-page: 207 issue: 2 year: 1990 Aug 15 ident: R80-2-20090810 publication-title: Int J Cancer doi: 10.1002/ijc.2910460211 – volume: 13 start-page: S44 year: 2006 ident: R102-2-20090810 publication-title: J Med Screen – year: 1975 ident: R20-2 – volume: 7 start-page: 11 issue: 1 year: 1985 May ident: R96-2-20090810 publication-title: Maturitas doi: 10.1016/0378-5122(85)90030-1 – volume: 14 start-page: 422 issue: 2 year: 2005 Feb ident: R125-2-20090810 publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-04-0411 – volume: 285 start-page: 3107 issue: 24 year: 2001 Jun 27 ident: R88-2-20090810 publication-title: JAMA doi: 10.1001/jama.285.24.3107 – volume: 36 start-page: 96 year: 2006 ident: R13-2-20090810 publication-title: J Natl Cancer Inst Monogr doi: 10.1093/jncimonographs/lgj013 – volume: 6 start-page: 132 issue: 3 year: 1999 ident: R34-2-20090810 publication-title: J Med Screen doi: 10.1136/jms.6.3.132 – volume: 6 start-page: 6 issue: 1 year: 2003 Jan-Feb ident: R177-2-20090810 publication-title: Value Health doi: 10.1046/j.1524-4733.2003.00003.x – volume: 5 start-page: 249 issue: 4 year: 2002 Nov ident: R144-2-20090810 publication-title: Health Care Manage Sci doi: 10.1023/A:1020326005465 – volume: 36 start-page: 56 year: 2006 ident: R77-2-20090810 publication-title: J Natl Cancer Inst Monogr doi: 10.1093/jncimonographs/lgj009 – volume: 34 start-page: 35 issue: 1 year: 1995 Oct ident: R95-2-20090810 publication-title: Health Policy doi: 10.1016/0168-8510(95)00720-D – volume: 95 start-page: 868 issue: 12 year: 2003 Jun 18 ident: R164-2-20090810 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/95.12.868 – volume: 353 start-page: 1784 issue: 17 year: 2005 Oct 27 ident: R30-2-20090810 publication-title: N Engl J Med doi: 10.1056/NEJMoa050518 – volume: 13 start-page: S54 year: 2006 ident: R176-2-20090810 publication-title: J Med Screen doi: 10.1258/096914106776179809 – volume: 151 start-page: 1158 issue: 12 year: 2000 June 15, 2000 ident: R11-2-20090810 publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a010166 – year: 1989 ident: R21-2 – volume: 36 start-page: 2177 issue: 17 year: 2000 Nov ident: R119-2-20090810 publication-title: Eur J Cancer doi: 10.1016/S0959-8049(00)00330-0 – volume: 31 start-page: 102 year: 2003 ident: R4-2-20090810 publication-title: J Natl Cancer Inst Monogr doi: 10.1093/oxfordjournals.jncimonographs.a003471 – year: 1997 ident: R15-2 – volume: 318 start-page: 356 issue: 7180 year: 1999 Feb 6 ident: R115-2-20090810 publication-title: BMJ doi: 10.1136/bmj.318.7180.356 – volume: 1 start-page: 103 issue: 2 year: 1998 Oct ident: R27-2-20090810 publication-title: Health Care Manage Sci doi: 10.1023/A:1019046619402 – volume: 91 start-page: 84 issue: 1 year: 2004 Jul 5 ident: R116-2-20090810 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6601884 – volume: 36 start-page: 1 issue: 1 year: 1982 Mar ident: R117-2-20090810 publication-title: J Epidemiol Community Health doi: 10.1136/jech.36.1.1 – volume: 159 start-page: 142 issue: 2 year: 1999 Jan 25 ident: R145-2-20090810 publication-title: Arch Intern Med doi: 10.1001/archinte.159.2.142 – volume: 47 start-page: 3 issue: 1 year: 1994 Jan ident: R163-2-20090810 publication-title: J Clin Epidemiol doi: 10.1016/0895-4356(94)90029-9 – volume: 40 start-page: 1272 issue: 6 year: 1996 Nov-Dec ident: R114-2-20090810 publication-title: Acta Cytol doi: 10.1159/000334021 – volume: 68 start-page: 141 issue: 806 year: 1995 Feb ident: R54-2-20090810 publication-title: Br J Radiol doi: 10.1259/0007-1285-68-806-141 – volume: 1 start-page: 190 issue: 3 year: 1989 ident: R24-2-20090810 publication-title: ORSA J Computing doi: 10.1287/ijoc.1.3.190 – volume: 37 start-page: 912 issue: 7 year: 2001 May ident: R133-2-20090810 publication-title: Eur J Cancer doi: 10.1016/S0959-8049(01)00057-0 – volume: 91 start-page: 1033 issue: 12 year: 1999 Jun 16 ident: R168-2-20090810 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/91.12.1033 – volume: 24 start-page: 3123 issue: 20 year: 2005 Oct 30 ident: R40-2-20090810 publication-title: Stat Med doi: 10.1002/sim.2178 – volume: 30 start-page: 1067 issue: 12 year: 1992 Dec ident: R98-2-20090810 publication-title: Med Care doi: 10.1097/00005650-199212000-00001 – volume: 162 start-page: 741 issue: 3 Pt 1 year: 1999 Sep ident: R167-2-20090810 publication-title: J Urol doi: 10.1097/00005392-199909010-00032 – volume: 87 start-page: 1217 issue: 16 year: 1995 Aug 16 ident: R43-2-20090810 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/87.16.1217 – volume: 10 start-page: 148 issue: 3 year: 2003 ident: R147-2-20090810 publication-title: J Med Screen doi: 10.1177/096914130301000310 – volume: 115 start-page: 807 issue: 10 year: 1991 Nov 15 ident: R138-2-20090810 publication-title: Ann Intern Med doi: 10.7326/0003-4819-115-10-807 – volume: 72 start-page: 1573 issue: 5 year: 1993 Sep 1 ident: R151-2-20090810 publication-title: Cancer doi: 10.1002/1097-0142(19930901)72:5<1573::AID-CNCR2820720514>3.0.CO;2-9 – volume: 4 start-page: 3 year: 1984 ident: R45-2-20090810 publication-title: Breast Cancer Res Treat doi: 10.1007/BF01806982 – volume: 297 start-page: 650 issue: 6649 year: 1988 Sep 10 ident: R57-2-20090810 publication-title: BMJ doi: 10.1136/bmj.297.6649.650 – volume: 47 start-page: 987 issue: 3 year: 1991 Sep ident: R175-2-20090810 publication-title: Biometrics doi: 10.2307/2532654 – volume: 36 start-page: 66 year: 2006 ident: R49-2-20090810 publication-title: J Natl Cancer Inst Monogr doi: 10.1093/jncimonographs/lgj010 – volume: 353 start-page: 2158 issue: 20 year: 2005 Nov 17 ident: R91-2-20090810 publication-title: N Engl J Med doi: 10.1056/NEJMsa044278 – volume: 92 start-page: 557 issue: 7 year: 2000 Apr 5 ident: R132-2-20090810 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/92.7.557 – volume: 17 start-page: 1179 issue: 5 year: 2008 May 1 ident: R8-2-20090810 publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-07-2539 – volume: 114 start-page: 546 issue: 7 year: 2003 May ident: R128-2-20090810 publication-title: Am J Med doi: 10.1016/S0002-9343(03)00095-0 – volume: 20 start-page: 434 issue: 4 year: 2004 Fall ident: R130-2-20090810 publication-title: Int J Technol Assess Health Care doi: 10.1017/S0266462304001321 – volume: 66 start-page: 1601 issue: 7 year: 1990 Oct 1 ident: R81-2-20090810 publication-title: Cancer doi: 10.1002/1097-0142(19901001)66:7<1601::AID-CNCR2820660727>3.0.CO;2-O – volume: 103 start-page: 619 issue: 4 year: 2004 Apr ident: R89-2-20090810 publication-title: Obstet Gynecol doi: 10.1097/01.AOG.0000120143.50098.c7 – volume: 287 start-page: 2382 issue: 18 year: 2002 May 8 ident: R99-2-20090810 publication-title: JAMA doi: 10.1001/jama.287.18.2382 – volume: 17 start-page: 785 issue: 5 year: 2006 May ident: R148-2-20090810 publication-title: Ann Oncol doi: 10.1093/annonc/mdl023 – volume: 14 start-page: 227 issue: 4 year: 1997 Dec ident: R159-2-20090810 publication-title: Community Dent Health – volume: 66 start-page: 1038 issue: 5 year: 2005 Nov ident: R173-2-20090810 publication-title: Urology doi: 10.1016/j.urology.2005.05.030 – volume: 115 start-page: 268 issue: 2 year: 2005 Jun 10 ident: R83-2-20090810 publication-title: Int J Cancer doi: 10.1002/ijc.20846 – volume: 35 start-page: 91 issue: 2 year: 2005 Feb ident: R38-2-20090810 publication-title: Comput Biol Med doi: 10.1016/j.compbiomed.2003.12.006 – volume: 4 start-page: 257 issue: 4 year: 2001 Dec ident: R121-2-20090810 publication-title: Health Care Manage Sci doi: 10.1023/A:1011886010184 – volume: 32 start-page: 13 issue: 1 year: 1999 Feb ident: R131-2-20090810 publication-title: Comput Biomed Res doi: 10.1006/cbmr.1998.1498 – volume: 36 start-page: 47 year: 2006 ident: R61-2-20090810 publication-title: J Natl Cancer Inst Monogr doi: 10.1093/jncimonographs/lgj008 – volume: 5 start-page: 3 issue: 1 year: 2003 Feb ident: R65-2-20090810 publication-title: J Wom Imag doi: 10.1097/00130747-200302000-00002 – volume: 76 start-page: 309 issue: 905 year: 2003 May ident: R28-2-20090810 publication-title: Br J Radiol doi: 10.1259/bjr/64009424 – volume: 12 start-page: 521 issue: 4 year: 2009 ident: R26-2-20090810 publication-title: Value Health doi: 10.1111/j.1524-4733.2008.00484.x – volume: 171 start-page: 155 issue: 2 year: 2001 Jun ident: R69-2-20090810 publication-title: Math Biosci doi: 10.1016/S0025-5564(01)00054-2 – volume: 7 start-page: 9 issue: 1 year: 1998 Feb ident: R124-2-20090810 publication-title: Health Econ doi: 10.1002/(SICI)1099-1050(199802)7:1<9::AID-HEC304>3.0.CO;2-H – volume: 28 start-page: 453 issue: 6 year: 2004 ident: R51-2-20090810 publication-title: Cancer Detect Prev doi: 10.1016/j.cdp.2004.08.003 – volume: 135 start-page: 769 issue: 9 year: 2001 Nov 6 ident: R127-2-20090810 publication-title: Ann Intern Med doi: 10.7326/0003-4819-135-9-200111060-00007 – volume: 94 start-page: 1469 issue: 19 year: 2002 Oct 2 ident: R105-2-20090810 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/94.19.1469 – volume: 19 start-page: 1117 issue: 5 year: 1990 Nov ident: R78-2-20090810 publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/0360-3016(90)90213-4 – volume: 31A start-page: 348 issue: 3 year: 1995 ident: R68-2-20090810 publication-title: Eur J Cancer doi: 10.1016/0959-8049(95)94001-F – volume: 92 start-page: 1531 issue: 6 year: 2001 Sep 15 ident: R152-2-20090810 publication-title: Cancer doi: 10.1002/1097-0142(20010915)92:6<1531::AID-CNCR1479>3.0.CO;2-P – volume: 40 start-page: e83 issue: 7 year: 2003 Jul ident: R52-2-20090810 publication-title: J Med Genet doi: 10.1136/jmg.40.7.e83 – volume: 61 start-page: 992 issue: 4 year: 2005 Dec ident: R73-2-20090810 publication-title: Biometrics doi: 10.1111/j.1541-0420.2005.00363.x – volume: 16 start-page: 799 issue: 3 year: 2000 Summer ident: R126-2-20090810 publication-title: Int J Technol Assess Health Care doi: 10.1017/S0266462300102077 – volume: 13 start-page: 421 year: 2004 Dec ident: R3-2-20090810 publication-title: Stat Methods Med Res doi: 10.1191/0962280204sm376ra – volume: 118 start-page: 2020 issue: 8 year: 2006 Apr 15 ident: R47-2-20090810 publication-title: Int J Cancer doi: 10.1002/ijc.21560 – volume: 6 start-page: 604 issue: 4 year: 2005 Oct ident: R74-2-20090810 publication-title: Biostatistics doi: 10.1093/biostatistics/kxi030 – volume: 107 start-page: 321 issue: 2 Pt 1 year: 2006 Feb ident: R104-2-20090810 publication-title: Obstet Gynecol doi: 10.1097/01.AOG.0000196500.50044.ce – year: 1990 ident: R108-2 – volume: 61 start-page: 903 issue: 6 year: 1990 Jun ident: R93-2-20090810 publication-title: Br J Cancer doi: 10.1038/bjc.1990.202 – volume: 13 start-page: S8 year: 2006 ident: R142-2-20090810 publication-title: J Med Screen doi: 10.1258/096914106776179782 – volume: 94 start-page: 193 issue: 3 year: 2002 Feb 6 ident: R120-2-20090810 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/94.3.193 – volume: 130 start-page: 97 issue: 2 year: 1999 Jan 19 ident: R87-2-20090810 publication-title: Ann Intern Med doi: 10.7326/0003-4819-130-2-199901190-00003 – volume: 33 start-page: 345 year: 2003 Jul ident: R36-2-20090810 publication-title: Comput Biol Med doi: 10.1016/S0010-4825(03)00003-9 – volume: 30 start-page: 1081 issue: 10 year: 1990 ident: R103-2-20090810 publication-title: Soc Sci Med doi: 10.1016/0277-9536(90)90294-3 – year: 2000 ident: R12-2 – volume: 96 start-page: 604 issue: 8 year: 2004 Apr 21 ident: R90-2-20090810 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djh104 – volume: 32 start-page: 227 issue: 3 year: 2001 Jun ident: R154-2-20090810 publication-title: Lung Cancer doi: 10.1016/S0169-5002(00)00239-7 – volume: 15 start-page: 429 issue: 3 year: 2006 Mar ident: R53-2-20090810 publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-05-0223 – volume: 284 start-page: 1399 issue: 11 year: 2000 Sep 20 ident: R172-2-20090810 publication-title: JAMA doi: 10.1001/jama.284.11.1399 – volume: 164 start-page: 245 year: 2004 Feb 9 ident: R106-2-20090810 publication-title: Arch Intern Med doi: 10.1001/archinte.164.3.245 – volume: 7 start-page: 21 issue: 1 year: 1998 Feb ident: R140-2-20090810 publication-title: Health Econ doi: 10.1002/(SICI)1099-1050(199802)7:1<21::AID-HEC306>3.0.CO;2-9 |
SSID | ssj0006372 |
Score | 2.2381613 |
SecondaryResourceType | review_article |
Snippet | Increasingly, computer simulation models are used for economic and policy evaluation in cancer prevention and control. A model’s predictions of key outcomes,... Increasingly, computer simulation models are used for economic and policy evaluation in cancer prevention and control. A model's predictions of key outcomes,... |
SourceID | pubmedcentral proquest gale repec pubmed pascalfrancis crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 533 |
SubjectTerms | Biological and medical sciences Calibration Calibration - standards Cancer Care and treatment Clinical trials Computer simulation Computer Simulation - standards Computer-generated environments Computerized, statistical medical data processing and models in biomedicine Cost benefit analysis Data Interpretation, Statistical Disease Editorials Epidemiology General aspects Guidelines as Topic Health Administration Health Economics Humans Management Medical care, Cost of Medical sciences Medical Subject Headings-MeSH Medicine Medicine & Public Health Methodology Methods Miscellaneous Models and simulation Models, Statistical Natural history Neoplasms - drug therapy Neoplasms - economics Pharmacoeconomics and Health Outcomes Pharmacology. Drug treatments Public Health Public health. Hygiene Public health. Hygiene-occupational medicine Quality of Life Research Review Article Technology application |
Title | Calibration Methods Used in Cancer Simulation Models and Suggested Reporting Guidelines |
URI | https://link.springer.com/article/10.2165/11314830-000000000-00000 https://www.ncbi.nlm.nih.gov/pubmed/19663525 http://econpapers.repec.org/article/wkhphecon/v_3a27_3ay_3a2009_3ai_3a7_3ap_3a533-545.htm https://www.proquest.com/docview/222286189 https://www.proquest.com/docview/67575813 https://pubmed.ncbi.nlm.nih.gov/PMC2787446 |
Volume | 27 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fb9MwELZgfQAJTTBgZIPiBzReFi12fvoJjbIxQJsquom-WY7jrBVbGpoW1P-euzhJVQ0BlZK6Tdy4vrN9Z_u-j5A3RgVZCnarG-Sp7waJF7pKR76rDIJF6cwIhsHJ5xfR2VXweRyOm705VbOtsu0T6446m2mcIz_iOFURsUS8K3-4SBqFi6sNg8Z90kPkMtzRFY87fwsG35q7qeZWicELtBt5OIvCI8Z88AP8OqjavmxqY3Rq-uhHpaqgvnJLdPEnS_Tuhsre3JRG31ldrQet08dku7E26bFVjyfknil2yIM2GLnaIQdDC129OqSX60is6pAe0OEa1Hr1lHzDIK7Uqgs9r2mnK3pVmYxOCzpA1ZnT0fS2IQOjSLF2U1FVZHS0vL6uJ1WpNfahoPTjEtG1cMf9MzI6PbkcnLkNKYMLImQL14hAB8oLtZenYaLBgBF5GMeeAhEjkA03Jop0ItI0wAoWnvYTL2NC81iEyn9OtopZYV4QmrMsCMMkN_BTgc5yIXJkPuYI4M8yFTokbkUhdYNXjrQZNxL8FhSibIUoOyHalENYl7O0mB3_kectSltis4anaNVEJ0BZESBLHnO0pWBkCBzS31CI7hEcoeVEwhyy32qIbDqESnbq65DX3VVoybg8owozW1YSXDdw3pjvkF2rTevCC7QLOVbJhp51NyBG-OaVYjqpscJ5jPwGkUMGtUZ2OX59n5QTnHKRP6WveAynFSbA5Ia3KRz4VQkH-AMSzGw5Wdw6hLf6vP5n_6rZvb9Wxz55aNfncFLrJdlazJfmFZh5i7RfN2Y4JwPWJ733JxfDr_Dpw5dPvwFMNkua |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dT9swED-x8sCkadrYV8YGftjYCxGx8-mHaWIMBuNDaIDgaVbiOLQapBlph_o37Z_cXb6qimnbC5XSWk3tuLnL-c72_X4Ab0zspQn6rbaXJa7tRY5vxzpw7dgQWJROjeSUnHxwGOycel_O_fM5-NXmwtC2ytYmVoY6HWqaI18XNFUR8Eh-KH7YRBpFi6stg0atFXtmcoMRW_l-9xOK960Q21snmzt2QypgYxf4yDbS017s-NrJEj_SOADLzA9DJ8YuEhCLMCYIdCSTBAMX15GOdiMn5VKLUPqxi63eg3nPxTimB_Mftw6PvnaGP3ArrqiKyyXEqLPeOCR44K9z7nJqznbaV12aGQ2bMeFBEZcon6wm1viT53t7A-f8tSmMvrWaWw2S24_gYePdso1aHR_DnMkXYaFNfi4XYfWohsqerLGTaeZXucZW2dEURHvyBM4oaSyp1ZMdVDTXJTstTcoGOdskVb1mx4OrhnyMEaXbZcniPGXH44uLahKX1cEFdpR9HhOaF-3wfwrHdyCvZ9DLh7l5ASzjqef7UWawKU-nmZQZMS0LIgzgaexbELaiULrBRyeajkuFcRIJUbVCVJ0Q65IFvKtZ1Bgh_1HnHUlbkRnBq-i4yYbAvhIgl9oQ5LvhSORZsDyjEN0lBEHZyYhbsNRqiGoMUKm6x8WCle4sWg5aDopzMxyXCkNFDBa5a8HzWpumnZfkhwq6JTN61v2AMMlnz-SDfoVNLkLiUwgs2Kw0sqtx871f9GmKR_1UbixCfJtQAV18_BjgQV8VeGD8odCtV_3RlQWi1efpP_vXnX3519uxAgs7Jwf7an_3cG8J7tdrgzSh9gp6o-uxeY0u5ihZbh5tBt_u1pb8BjLnhBc |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbGJgESQjBuYbD5AcbLosbO1Q8ITR1lY2yq1E30CctxnLViS0PTMvWX8fc4J7eqGgJeVimt1dSO63N8LrbP-Qh5Y5SXxGC32l4au7YXOb6tdODaymCyKJ0YwTA4-eQ0ODz3Pg_94Rr51cTC4LHKRiaWgjqZaFwj73BcqghYJDppfSqif9D7kP-wEUAKN1obNI2KQ47N4hq8t-L90QGQ-i3nvY9n3UO7BhiwoTtsZhvhaU85vnbS2I80KGOR-mHoKOguJmXhxgSBjkQcgxPjOsLRbuQkTGgeCl-50OodshG6PsMJFg5bTw_UfokaVaK6hOB_VkeIOAv8DmMuw8Zsp3lVpRW9WGuHB7kqgFJpBbHxJxv45lHOjanJjb6xr1uqy94j8rC2c-l-xZiPyZrJNsm9Jgy62CS7_Spp9mKPni1jwIo9ukv7y3TaiyfkK4aPxRWj0pMS8Lqg54VJ6DijXWTaKR2Mr2oYMorgbpcFVVlCB_OLi3I5l1ZuBnSUfppjXi886_-UDG6BWs_IejbJzAtCU5Z4vh-lBprydJIKkSLmMkfoAJYo3yJhQwqp60zpCNhxKcFjQiLKhoiyJWJVsghra-ZVtpD_qPMOqS1RoMBTtKrjIqCvmJpL7nO04kAneRbZXmGI9hEck9qJiFlkq-EQWYuiQrYTxyI77V2QIbgxpDIzmRcSnEZwG5lrkecVNy07L9Ai5TgkK3zW_gCzk6_eycajMks5DxFZIbBIt-TItsb191E-wsUe-VO6iofwtsACGPvwMYYLv8rhAk9EgoEvR7Mri_CGn5f_7F8j-_Kvw7FD7oIEkV-OTo-3yP1qkxBX1l6R9dl0bl6DrTmLt8t5Tcm32xUjvwFRC4bn |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Calibration+methods+used+in+cancer+simulation+models+and+suggested+reporting+guidelines&rft.jtitle=PharmacoEconomics&rft.au=Stout%2C+Natasha+K&rft.au=Knudsen%2C+Amy+B&rft.au=Kong%2C+Chung+Yin&rft.au=McMahon%2C+Pamela+M&rft.date=2009-01-01&rft.issn=1170-7690&rft.volume=27&rft.issue=7&rft.spage=533&rft_id=info:doi/10.2165%2F11314830-000000000-00000&rft_id=info%3Apmid%2F19663525&rft.externalDocID=19663525 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1170-7690&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1170-7690&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1170-7690&client=summon |